Ident. | Authors (with country if any) | Title |
---|
000020 |
Andrew J. Lees [Royaume-Uni] ; Joaquim Ferreira [Portugal] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; José-Francisco Rocha [Portugal] ; Michelle Mccrory [Irlande (pays)] ; Patricio Soares-Da-Silva [Portugal] | Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial. |
000117 |
Julia Dupouy [France] ; Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] | [Other care in Parkinson's disease: Psychological, rehabilitation, therapeutic education and new technologies]. |
000126 |
Jorik Nonnekes [Pays-Bas] ; Monique H M. Timmer [Pays-Bas] ; Nienke M. De Vries [Pays-Bas] ; Olivier Rascol [France] ; Rick C. Helmich [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] | Unmasking levodopa resistance in Parkinson's disease. |
000129 |
Nadège Calmels [France] ; Géraldine Greff [France] ; Cathy Obringer [France] ; Nadine Kempf [France] ; Claire Gasnier [France] ; Julien Tarabeux [France] ; Marguerite Miguet [France] ; Geneviève Baujat [France] ; Didier Bessis [France] ; Patricia Bretones [France] ; Anne Cavau [France] ; Béatrice Digeon [France] ; Martine Doco-Fenzy [France] ; Bérénice Doray [France] ; François Feillet [France] ; Jesus Gardeazabal [Espagne] ; Blanca Gener [Espagne] ; Sophie Julia [France] ; Isabel Llano-Rivas [Espagne] ; Artur Mazur [Pologne] ; Caroline Michot [France] ; Florence Renaldo-Robin [France] ; Massimiliano Rossi [France] ; Pascal Sabouraud [France] ; Boris Keren [France] ; Christel Depienne [France] ; Jean Muller [France] ; Jean-Louis Mandel [France] ; Vincent Laugel [France] | Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing |
000181 |
Sophie Drapier [France] ; Alexandre Eusebio [France] ; Bertrand Degos [France] ; Marc Vérin [France] ; Franck Durif [France] ; Jean Philippe Azulay [France] ; François Viallet [France] ; Tiphaine Rouaud [France] ; Caroline Moreau [France] ; Luc Defebvre [France] ; Valerie Fraix [France] ; Christine Tranchant [France] ; Karine Andre [France] ; Christine Brefel Courbon [France] ; Emmanuel Roze [France] ; David Devos [France] | Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort study. |
000194 |
Santiago Perez-Lloret [Argentine] ; Olivier Rascol [France] | Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease. |
000220 |
C. Foguem [France] ; B. Kamsu-Foguem [France] | Neurodegeneration in tauopathies and synucleinopathies. |
000231 |
Waqas Tahir [Allemagne] ; Saima Zafar [Allemagne] ; Franc Llorens [Allemagne] ; Amandeep Singh Arora [Allemagne] ; Katrin Thüne [Allemagne] ; Matthias Schmitz [Allemagne] ; Nadine Gotzmann [Allemagne] ; Niels Kruse [Allemagne] ; Brit Mollenhauer [Allemagne] ; Juan Maria Torres [Espagne] ; Olivier Andréoletti [France] ; Isidre Ferrer [Espagne] ; Inga Zerr [Allemagne] | Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress. |
000245 |
Olivier Rascol [France] ; Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Cheryl J. Fitzer-Attas [États-Unis] ; Yulia Sidi [Israël] ; Victor Abler [États-Unis] ; C Warren Olanow [États-Unis] | Long-term effects of rasagiline and the natural history of treated Parkinson's disease. |
000261 |
Isabelle Rieu [France] ; Jean Luc Houeto [France] ; Bruno Pereira [France] ; Ingrid De Chazeron [France] ; Amélie Bichon [France] ; Isabelle Chéreau [France] ; Miguel Ulla [France] ; Christine Brefel-Courbon [France] ; Fabienne Ory-Magne [France] ; Kathy Dujardin [France] ; François Tison [France] ; Paul Krack [France] ; Franck Durif [France] | Impact of Mood and Behavioral Disorders on Quality of Life in Parkinson's disease. |
000266 |
Patrice D. Cani [Belgique, France] ; Claude Knauf [France, Belgique] | How gut microbes talk to organs: The role of endocrine and nervous routes |
000270 |
Julien Thevenon [France] ; Gabriel Laurent [France] ; Flavie Ader [France] ; Pascal Laforêt [France] ; Didier Klug [France] ; Anju Duva Pentiah [France] ; Laurent Gouya [France] ; Claude Alain Maurage [France] ; Salem Kacet [France] ; Jean-Christophe Eicher [France] ; Juliette Albuisson [France] ; Michel Desnos [France] ; Eric Bieth [France] ; Denis Duboc [France] ; Laurent Martin [France] ; Patricia Réant [France] ; François Picard [France] ; Claire Bonithon-Kopp [France] ; Elodie Gautier [France] ; Christine Binquet [France] ; Christel Thauvin-Robinet [France] ; Laurence Faivre [France] ; Patrice Bouvagnet [France] ; Philippe Charron [France] ; Pascale Richard [France] | High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations. |
000278 |
K. Dujardin [France] ; N. Auzou [France] ; E. Lhommée [France] ; V. Czernecki [France] ; B. Dubois [France] ; A. Fradet [France] ; D. Maltete [France] ; M. Meyer [France] ; F. Pineau [France] ; E. Schmitt [France] ; F. Sellal [France] ; F. Tison [France] ; T. Vidal [France] ; J-P Azulay [France] ; M-L Welter [France] ; J-C Corvol [France] ; F. Durif [France] ; O. Rascol [France] | French consensus procedure for assessing cognitive function in Parkinson's disease. |
000331 |
Cindy Canivet [France] ; Nadège Costa [France] ; Fabienne Ory-Magne [France] ; Céline Arcari [France] ; Christine Mohara [France] ; Laure Pourcel [France] ; Hélène Derumeaux [France] ; Emilie Bérard [France] ; Robert Bourrel [France] ; Laurent Molinier [France] ; Christine Brefel-Courbon [France] | Clinical Impact and Cost-Effectiveness of an Education Program for PD Patients: A Randomized Controlled Trial |
000347 |
Sibylle De Germay [France] ; Jean-Louis Montastruc [France] ; Vanessa Rousseau [France] ; Leila Chebane [France] ; Emmanuelle Bondon-Guitton [France] ; Florence Moulis [France] ; Genevieve Durrieu [France] ; Haleh Bagheri [France] ; Olivier Rascol [France] ; Antoine Pariente [France] ; Bernard Bégaud [France] ; François Montastruc [France] | Atropinic (Anticholinergic) Burden in Parkinson's Disease. |
000372 |
S. Bayard [France] ; E. Joly [Suisse] ; P. Ghisletta [Suisse] ; A. Rossignol [France] ; Y. Herades [France] ; C. Geny [France] ; M-C Gély-Nargeot [France] ; L. Rochat [Suisse] | A multidimensional approach to impulsivity in Parkinson's disease: measurement and structural invariance of the UPPS Impulsive Behaviour Scale. |
000375 |
Olivier Rascol [France] ; Theresa Zesiewicz [États-Unis] ; K Ray Chaudhuri [Royaume-Uni] ; Mahnaz Asgharnejad [États-Unis] ; Erwin Surmann [Allemagne] ; Elisabeth Dohin [Belgique] ; Sigrid Nilius [Allemagne] ; Lars Bauer [Allemagne] | A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain. |
000376 |
Claudia Trenkwalder [Allemagne] ; Daniela Berg [Allemagne] ; Olivier Rascol [France] ; Karla Eggert [Allemagne] ; Andres Ceballos-Baumann [Allemagne] ; Jean-Christophe Corvol [France] ; Alexander Storch [Allemagne] ; Lin Zhang [États-Unis] ; Jean-Philippe Azulay [France] ; Emmanuel Broussolle [France] ; Luc Defebvre [France] ; Christian Geny [France] ; Michal Gostkowski [États-Unis] ; Fabrizio Stocchi [Italie] ; Christine Tranchant [France] ; Pascal Derkinderen [France] ; Franck Durif [France] ; Alberto J. Espay [États-Unis] ; Andrew Feigin [États-Unis] ; Jean-Luc Houeto [France] ; Johannes Schwarz [Allemagne] ; Thérèse Di Paolo [Canada] ; Dominik Feuerbach [Suisse] ; Hans-Ulrich Hockey [Suisse] ; Judith Jaeger [États-Unis] ; Annamaria Jakab [Suisse] ; Donald Johns [États-Unis] ; Gurutz Linazasoro [Espagne] ; Paul Maruff [États-Unis] ; Izabela Rozenberg [Suisse] ; Judit Sovago [Suisse] ; Markus Weiss [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia. |
000377 |
François Tison [France] ; Charlotte Keywood [Suisse] ; Mark Wakefield [Suisse] ; Franck Durif [France] ; Jean-Christophe Corvol [France] ; Karla Eggert [Allemagne] ; Mark Lew [États-Unis] ; Stuart Isaacson [États-Unis] ; Erwan Bezard [France] ; Sonia-Maria Poli [Suisse] ; Christopher G. Goetz [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Olivier Rascol [France] | A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease. |
000449 |
X. Gamé [France] | [Neurodegenerative diseases 2014-2019: A plan without perineum]. |
000450 |
J. Romain [France] ; F. Torny [France] ; J-P Dumas [France] ; X. Gamé [France] ; A. Descazeaud [France] | [Is nocturnal polyuria more frequent among patients with Parkinson's disease?]. |
000481 |
Michael R. Paillasse [France] ; Philippe De Medina [France] | The NR4A nuclear receptors as potential targets for anti-aging interventions. |
000502 |
Pietro-Luca Ratti [Suisse] ; Laurence Nègre-Pagès [France] ; Santiago Pérez-Lloret [France] ; Raffaele Manni [Italie] ; Philippe Damier [France] ; François Tison [France] ; Alain Destée [France] ; Olivier Rascol [France] | Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort. |
000512 |
Allan Colver [Royaume-Uni] ; Marion Rapp [Allemagne] ; Nora Eisemann [Allemagne] ; Virginie Ehlinger [France] ; Ute Thyen [Allemagne] ; Heather O. Dickinson [Royaume-Uni] ; Jackie Parkes [Royaume-Uni] ; Kathryn Parkinson [Royaume-Uni] ; Malin Nystrand [Suède] ; Jérôme Fauconnier [France] ; Marco Marcelli [Italie] ; Susan I. Michelsen [Danemark] ; Catherine Arnaud [France] | Self-reported quality of life of adolescents with cerebral palsy: a cross-sectional and longitudinal analysis. |
000525 |
Thierry Paillard [France] ; Yves Rolland [France] ; Philipe De Souto Barreto [France] | Protective Effects of Physical Exercise in Alzheimer's Disease and Parkinson's Disease: A Narrative Review |
000527 |
Claudia Trenkwalder [Allemagne] ; K Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Reinhard Ehret [Allemagne] ; Martin Vališ [République tchèque] ; Maria Sátori [Hongrie] ; Anna Krygowska-Wajs [Pologne] ; Maria J. Marti [Espagne] ; Karen Reimer [Allemagne] ; Alexander Oksche [Allemagne] ; Mark Lomax [Royaume-Uni] ; Julia Decesare [Royaume-Uni] ; Michael Hopp [Allemagne] | Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial. |
000531 |
Thierry Paillard [France] | Preventive effects of regular physical exercise against cognitive decline and the risk of dementia with age advancement |
000535 |
Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Susan B. Huyck [États-Unis] ; Rachel Capece [États-Unis] ; Tony W. Ho [États-Unis] ; Peter Sklar [États-Unis] ; Christopher Lines [États-Unis] ; David Michelson [États-Unis] ; David Hewitt [États-Unis] | Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned. |
000537 |
Caroline Moreau [France] ; Sayah Meguig [France] ; Jean-Christophe Corvol [France] ; Julien Labreuche [France] ; Francis Vasseur [France] ; Alain Duhamel [France] ; Arnaud Delval [France] ; Thomas Bardyn [France] ; Jean-Christophe Devedjian [France] ; Nathalie Rouaix [France] ; Gregory Petyt [France] ; Christine Brefel-Courbon [France] ; Fabienne Ory-Magne [France] ; Dominique Guehl [France] ; Alexandre Eusebio [France] ; Valérie Fraix [France] ; Pierre-Jean Saulnier [France] ; Ouhaid Lagha-Boukbiza [France] ; Frank Durif [France] ; Mirela Faighel [France] ; Caroline Giordana [France] ; Sophie Drapier [France] ; David Maltête [France] ; Christine Tranchant [France] ; Jean-Luc Houeto [France] ; Bettina Debû [France] ; Jean-Philippe Azulay [France] ; François Tison [France] ; Alain Destée [France] ; Marie Vidailhet [France] ; Olivier Rascol [France] ; Kathy Dujardin [France] ; Luc Defebvre [France] ; Régis Bordet [France] ; Bernard Sablonnière [France] ; David Devos [France] | Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease. |
000547 |
Federico Nemmi [France] ; Umberto Sabatini [Italie] ; Olivier Rascol [France] ; Patrice Péran [France] | Parkinson's disease and local atrophy in subcortical nuclei: insight from shape analysis. |
000573 |
H. Iderberg [Suède] ; A C Mccreary [Pays-Bas] ; M A Varney [États-Unis] ; M S Kleven [France] ; W. Koek [France] ; L. Bardin [France] ; R. Depoortère [France] ; M A Cenci [Suède] ; A. Newman-Tancredi [États-Unis] | NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat. |
000582 |
Laurent Cleret De Langavant [France] ; Sophie Sudraud [France] ; Christophe Verny [France] ; Pierre Krystkowiak [France] ; Clémence Simonin [France] ; Philippe Damier [France] ; Jean-François Demonet [Suisse, France] ; Frédéric Supiot [Belgique] ; Amandine Rialland [France] ; David Schmitz [France] ; Patrick Maison [France] ; Katia Youssov [France] ; Anne-Catherine Bachoud-Lévi [France] | Longitudinal Study of Informed Consent in Innovative Therapy Research: Experience and Provisional Recommendations from a Multicenter Trial of Intracerebral Grafting |
000590 |
K Ray Chaudhuri [Royaume-Uni] ; A. Rizos [Royaume-Uni] ; C. Trenkwalder [Allemagne] ; O. Rascol [France] ; S. Pal [Royaume-Uni] ; D. Martino [Royaume-Uni] ; C. Carroll [Royaume-Uni] ; D. Paviour [Royaume-Uni] ; C. Falup-Pecurariu [Roumanie] ; B. Kessel [Royaume-Uni] ; M. Silverdale [Royaume-Uni] ; A. Todorova [Royaume-Uni] ; A. Sauerbier [Royaume-Uni] ; P. Odin [Suède] ; A. Antonini [Italie] ; P. Martinez-Martin [Espagne] | King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation. |
000603 |
Laure-Estelle Cassagnes [France] ; Pierre Perio [France] ; Gilles Ferry [France] ; Natacha Moulharat [France] ; Mathias Antoine [France] ; Régis Gayon [France] ; Jean A. Boutin [France] ; Françoise Nepveu [France] ; Karine Reybier [France] | In cellulo monitoring of quinone reductase activity and reactive oxygen species production during the redox cycling of 1,2 and 1,4 quinones. |
000608 |
Clive Ballard [Royaume-Uni] ; Stuart Isaacson [États-Unis] ; Roger Mills [États-Unis] ; Hilde Williams [États-Unis] ; Anne Corbett [Royaume-Uni] ; Bruce Coate [États-Unis] ; Rajesh Pahwa [États-Unis] ; Olivier Rascol [France] ; David J. Burn [Royaume-Uni] | Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis. |
000624 |
Rahul S. Desikan [États-Unis] ; Andrew J. Schork [États-Unis] ; Yunpeng Wang [États-Unis, Norvège] ; Aree Witoelar [Norvège] ; Manu Sharma [Allemagne] ; Linda K. Mcevoy [États-Unis] ; Dominic Holland [États-Unis] ; James B. Brewer [États-Unis] ; Chi-Hua Chen [États-Unis] ; Wesley K. Thompson [États-Unis] ; Denise Harold ; Julie Williams ; Michael J. Owen ; Michael C. O Onovan ; Margaret A. Pericak-Vance [États-Unis] ; Richard Mayeux [États-Unis] ; Jonathan L. Haines [États-Unis] ; Lindsay A. Farrer [États-Unis] ; Gerard D. Schellenberg [États-Unis] ; Peter Heutink [Allemagne] ; Andrew B. Singleton [États-Unis] ; Alexis Brice [France] ; Nicolas W. Wood [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Maria Martinez [France] ; Seung Hoi Choi [États-Unis] ; Anita Destefano [États-Unis] ; M. Arfan Ikram [Pays-Bas] ; Joshua C. Bis [États-Unis] ; Albert Smith [Islande] ; Annette L. Fitzpatrick [États-Unis] ; Lenore Launer [États-Unis] ; Cornelia Van Duijn [Pays-Bas] ; Sudha Seshadri [États-Unis] ; Ingun Dina Ulstein [Norvège] ; Dag Aarsland [Norvège] ; Tormod Fladby [Norvège] ; Srdjan Djurovic [Norvège] ; Bradley T. Hyman [États-Unis] ; Jon Snaedal [Islande] ; Hreinn Stefansson [Islande] ; Kari Stefansson [Islande] ; Thomas Gasser [Allemagne] ; Ole A. Andreassen [États-Unis, Norvège] ; Anders M. Dale [États-Unis] | Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus |
000636 |
Olivier Rascol [France] ; Santiago Perez-Lloret [France] ; Philippe Damier [France] ; Arnaud Delval [France] ; Pascal Derkinderen [France] ; Alain Destée [France] ; Wassilios G. Meissner [France] ; Francois Tison [France] ; Laurence Negre-Pages [France] | Falls in ambulatory non-demented patients with Parkinson's disease. |
000647 |
A. Antonini [Italie] ; L. Bauer [Allemagne] ; E. Dohin [France] ; W H Oertel [Allemagne] ; O. Rascol [France] ; H. Reichmann [Allemagne] ; M. Schmid [Allemagne] ; P. Singh [Allemagne] ; E. Tolosa [Espagne] ; K Ray Chaudhuri [Royaume-Uni] | Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial. |
000661 |
Pietro-Luca Ratti [France, Suisse] ; Maria Sierra-Pe A [France] ; Raffaele Manni [Italie] ; Marion Simonetta-Moreau [France] ; Julien Bastin [France] ; Harrison Mace [France] ; Olivier Rascol [France] ; Olivier David [France] | Distinctive Features of NREM Parasomnia Behaviors in Parkinson’s Disease and Multiple System Atrophy |
000667 |
Mike A. Nalls [États-Unis] ; Cory Y. Mclean [États-Unis] ; Jacqueline Rick [États-Unis] ; Shirley Eberly [États-Unis] ; Samantha J. Hutten [États-Unis] ; Katrina Gwinn [États-Unis] ; Margaret Sutherland [États-Unis] ; Maria Martinez [France] ; Peter Heutink [Allemagne] ; Nigel Williams ; John Hardy [Royaume-Uni] ; Thomas Gasser [Allemagne] ; Alexis Brice [France] ; T. Ryan Price [États-Unis] ; Aude Nicolas [États-Unis] ; Margaux F. Keller [États-Unis] ; Cliona Molony [États-Unis] ; J. Raphael Gibbs [États-Unis] ; Alice Chen-Plotkin [États-Unis] ; Eunran Suh [États-Unis] ; Christopher Letson [États-Unis] ; Massimo S. Fiandaca [États-Unis] ; Mark Mapstone [États-Unis] ; Howard J. Federoff [États-Unis] ; Alastair J. Noyce [Royaume-Uni] ; Huw Morris [Royaume-Uni] ; Vivianna M. Van Deerlin [États-Unis] ; Daniel Weintraub [États-Unis] ; Cyrus Zabetian [États-Unis] ; Dena G. Hernandez [États-Unis] ; Suzanne Lesage [France] ; Meghan Mullins [États-Unis] ; Emily Drabant Conley [États-Unis] ; Carrie Northover [États-Unis] ; Mark Frasier [États-Unis] ; Ken Marek [États-Unis] ; Aaron G. Day-Williams [États-Unis] ; David J. Stone [États-Unis] ; John P. A. Ioannidis [États-Unis] ; Andrew B. Singleton [États-Unis] | Diagnosis of Parkinson’s disease on the basis of clinical–genetic classification: a population-based modelling study |
000680 |
Pierre-François Roux [France] ; Simon Boitard [France] ; Yuna Blum [États-Unis] ; Brian Parks [États-Unis] ; Alexandra Montagner [France] ; Etienne Mouisel [France] ; Anis Djari [France] ; Diane Esquerré [France] ; Colette Désert [France] ; Morgane Boutin [France] ; Sophie Leroux [France] ; Frédéric Lecerf [France] ; Elisabeth Le Bihan-Duval [France] ; Christophe Klopp [France] ; Bertrand Servin [France] ; Frédérique Pitel [France] ; Michel Jean Duclos [France] ; Hervé Guillou [France] ; Aldons J. Lusis [États-Unis] ; Olivier Demeure [France] ; Sandrine Lagarrigue [France] | Combined QTL and Selective Sweep Mappings with Coding SNP Annotation and cis-eQTL Analysis Revealed PARK2 and JAG2 as New Candidate Genes for Adiposity Regulation |
000682 |
P. Odin [Allemagne] ; K. Ray Chaudhuri [Royaume-Uni] ; J T Slevin [États-Unis] ; J. Volkmann [Allemagne] ; E. Dietrichs [Norvège] ; P. Martinez-Martin [Espagne] ; J K Krauss [Allemagne] ; T. Henriksen [Danemark] ; R. Katzenschlager [Autriche] ; A. Antonini [Italie] ; O. Rascol [France] ; Werner Poewe [Autriche] | Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program. |
000807 |
F. Ory Magne [France] ; C. Arcari [France] ; C. Canivet [France] ; M. Sarrail [France] ; M H Fabre [France] ; C. Mohara [France] ; C. Brefel Courbon [France] | [A therapeutic educational program in Parkinson's disease: ETPARK]. |
000815 |
Olivier Rascol [France] ; Susan Fox [Canada] ; Fabrizio Gasparini [Suisse] ; Christopher Kenney [États-Unis] ; Thérèse Di Paolo [Canada] ; Baltazar Gomez-Mancilla [Canada] | Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias. |
000827 |
Aurore Curie [France, États-Unis] ; Tatjana Nazir [France] ; Amandine Brun [France] ; Yves Paulignan [France] ; Anne Reboul [France] ; Karine Delange [France] ; Anne Cheylus [France] ; Sophie Bertrand [France] ; Fanny Rochefort [France] ; Gérald Bussy [France] ; Stéphanie Marignier [France] ; Didier Lacombe [France] ; Catherine Chiron [France] ; Mireille Cossée [France] ; Bruno Leheup [France] ; Christophe Philippe [France] ; Vincent Laugel [France] ; Anne De Saint Martin [France] ; Silvia Sacco [France] ; Karine Poirier [France] ; Thierry Bienvenu [France] ; Isabelle Souville [France] ; Brigitte Gilbert-Dussardier [France] ; Eric Bieth [France] ; Didier Kauffmann [France] ; Philippe Briot [France] ; Bénédicte De Fréminville [France] ; Fabienne Prieur [France] ; Michel Till [France] ; Caroline Rooryck-Thambo [France] ; Isabelle Mortemousque [France] ; Isabelle Bobillier-Chaumont [France] ; Annick Toutain [France] ; Renaud Touraine [France] ; Damien Sanlaville [France] ; Jamel Chelly [France] ; Sonya Freeman [États-Unis] ; Jian Kong [États-Unis] ; Nouchine Hadjikhani [États-Unis] ; Randy L. Gollub [États-Unis] ; Alice Roy [France] ; Vincent Des Portes [France] | The c.429_452 duplication of the ARX gene: a unique developmental-model of limb kinetic apraxia |
000838 |
Patrice Péran [France] ; Sheila Catani ; Chiara Falletta Caravasso ; Federico Nemmi ; Umberto Sabatini ; Rita Formisano | Supplementary motor area activation is impaired in severe traumatic brain injury parkinsonism. |
000872 |
Santiago Perez-Lloret ; Laurence Negre-Pages [France] ; Philippe Damier [France] ; Arnaud Delval [France] ; Pascal Derkinderen [France] ; Alain Destée [France] ; Wassilios G. Meissner [France] ; Ludwig Schelosky [Suisse] ; Francois Tison [France] ; Olivier Rascol | Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease. |
000873 |
Van Mô Dang [France] ; Allan Colver [Royaume-Uni] ; Heather O. Dickinson [Royaume-Uni] ; Marco Marcelli [Italie] ; Susan I. Michelsen [Danemark] ; Jackie Parkes [Royaume-Uni] ; Kathryn Parkinson [Royaume-Uni] ; Marion Rapp [Allemagne] ; Catherine Arnaud [France] ; Malin Nystrand [Suède] ; Jérôme Fauconnier [France] | Predictors of participation of adolescents with cerebral palsy: A European multi-centre longitudinal study. |
000895 |
Olivier Rascol [France] | Parkinson disease: Can a new trial end controversy over when to use levodopa? |
000915 |
Nina Kaludercic [Italie] ; Jeanne Mialet-Perez [France] ; Nazareno Paolocci [États-Unis] ; Angelo Parini [France] ; Fabio Di Lisa [Italie] | Monoamine oxidases as sources of oxidants in the
heart |
000923 |
Robert A. Hauser [États-Unis] ; Mark Forrest Gordon [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Paolo Barone [Italie] ; Anthony H. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Catherine Debieuvre [France] ; Mandy Fr Dorf [Allemagne] | Minimal Clinically Important Difference in Parkinson's Disease as Assessed in Pivotal Trials of Pramipexole Extended Release |
000931 |
Stéphane Palfi [France] ; Jean Marc Gurruchaga [France] ; G Scott Ralph [Royaume-Uni] ; Helene Lepetit [France] ; Sonia Lavisse [France] ; Philip C. Buttery [Royaume-Uni] ; Colin Watts [Royaume-Uni] ; James Miskin [Royaume-Uni] ; Michelle Kelleher [Royaume-Uni] ; Sarah Deeley [Royaume-Uni] ; Hirokazu Iwamuro [France] ; Jean Pascal Lefaucheur [France] ; Claire Thiriez [France] ; Gilles Fenelon [France] ; Cherry Lucas [Royaume-Uni] ; Pierre Brugières [France] ; Inanna Gabriel [France] ; Kou Abhay [France] ; Xavier Drouot [France] ; Naoki Tani [France] ; Aurelie Kas [France] ; Bijan Ghaleh [France] ; Philippe Le Corvoisier [France] ; Patrice Dolphin [France] ; David P. Breen [Royaume-Uni] ; Sarah Mason [Royaume-Uni] ; Natalie Valle Guzman [Royaume-Uni] ; Nicholas D. Mazarakis [Royaume-Uni] ; Pippa A. Radcliffe [Royaume-Uni] ; Richard Harrop [Royaume-Uni] ; Susan M. Kingsman [Royaume-Uni] ; Olivier Rascol [France] ; Stuart Naylor [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Pierre Cesaro [France] ; Kyriacos A. Mitrophanous [Royaume-Uni] | Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. |
000936 |
Mike A. Nalls [États-Unis] ; Nathan Pankratz [États-Unis] ; Christina M. Lill [Allemagne] ; Chuong B. Do [États-Unis] ; Dena G. Hernandez [États-Unis] ; Mohamad Saad [États-Unis, France] ; Anita L. Destefano [États-Unis] ; Eleanna Kara [Royaume-Uni] ; Jose Bras [Royaume-Uni] ; Manu Sharma [Allemagne] ; Claudia Schulte [Allemagne] ; Margaux F. Keller [États-Unis] ; Sampath Arepalli [États-Unis] ; Christopher Letson [États-Unis] ; Connor Edsall [États-Unis] ; Hreinn Stefansson [Islande] ; Xinmin Liu [États-Unis] ; Hannah Pliner [États-Unis] ; Joseph H. Lee [États-Unis] ; Rong Cheng [États-Unis] ; M. Arfan Ikram [Pays-Bas] ; John P. A. Ioannidis [États-Unis] ; Georgios M. Hadjigeorgiou [Grèce] ; Joshua C. Bis [États-Unis] ; Maria Martinez [France] ; Joel S. Perlmutter [États-Unis] ; Alison Goate [États-Unis] ; Karen Marder [États-Unis] ; Brian Fiske [États-Unis] ; Margaret Sutherland [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Richard H. Myers [États-Unis] ; Lorraine N. Clark [États-Unis] ; Kari Stefansson [Islande] ; John A. Hardy ; Peter Heutink [Allemagne] ; Honglei Chen [États-Unis] ; Nicholas W. Wood [Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; Haydeh Payami [États-Unis] ; Alexis Brice [France] ; William K. Scott [États-Unis] ; Thomas Gasser [Allemagne] ; Lars Bertram [Allemagne] ; Nicholas Eriksson [États-Unis] ; Tatiana Foroud [États-Unis] ; Andrew B. Singleton [États-Unis] | Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease |
000939 |
Olivier Rascol [France] | Jejunal levodopa infusion in Parkinson's disease. |
000960 |
Marie Tosolini [France] ; Frédéric Pont [France] ; Delphine Bétous [France] ; Emmanuel Ravet [France] ; Laetitia Ligat [France] ; Frédéric Lopez [France] ; Mary Poupot [France] ; Marc Poirot [France] ; Éric Pérouzel [France] ; Gérard Tiraby [France] ; Els Verhoeyen [France] ; Jean-Jacques Fournié [France] | Human Monocyte Recognition of Adenosine-Based Cyclic Dinucleotides Unveils the A2a Gαs Protein-Coupled Receptor Tonic Inhibition of Mitochondrially Induced Cell Death |
000980 |
Gaëlle Hautefeuille [France] ; Jean Lapuelle [France] ; Stanislas Chaussade [France] ; Thierry Ponchon [France] ; B Richard Molard [France] ; Pierre Coulom [France] ; René Laugier [France] ; Franck Henri [France] ; Guillaume Cadiot [France] | Factors related to bowel cleansing failure before colonoscopy: Results of the PACOME study |
000983 |
Susan I. Michelsen [Danemark] ; Esben M. Flachs [Danemark] ; Mogens T. Damsgaard [Danemark] ; Jacqueline Parkes [Irlande (pays)] ; Kathryn Parkinson [Royaume-Uni] ; Marion Rapp [Allemagne] ; Catherine Arnaud [France] ; Malin Nystrand [Suède] ; Allan Colver [Royaume-Uni] ; Jerome Fauconnier [France] ; Heather O. Dickinson [Royaume-Uni] ; Marco Marcelli [Italie] ; Peter Uldall [Danemark] | European study of frequency of participation of adolescents with and without cerebral palsy. |
000A17 |
Jean Pellaprat [France] ; Fabienne Ory-Magne [France] ; Cindy Canivet [France] ; Marion Simonetta-Moreau [France] ; Jean-Albert Lotterie [France] ; Fatai Radji [France] ; Christophe Arbus [France] ; Angélique Gerdelat [France] ; Patrick Chaynes [France] ; Christine Brefel-Courbon [France] | Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease. |
000A69 |
Marion Szelechowski [France] ; Alexandre Bétourné [France] ; Yann Monnet [France] ; Cécile A. Ferré [France] ; Anne Thouard [France] ; Charlotte Foret [France] ; Jean-Michel Peyrin [France] ; Stéphane Hunot [France] ; Daniel Gonzalez-Dunia [France] | A viral peptide that targets mitochondria protects against neuronal degeneration in models of Parkinson's disease. |
000A83 |
F. Ory Magne [France] ; C. Arcari [France] ; C. Canivet [France] ; M. Sarrail [France] ; M. H. Fabre [France] ; C. Mohara [France] ; C. Brefel Courbon [France] | Éducation thérapeutique chez le patient parkinsonien: le programme ETPARK |
000A95 |
Fabienne Ory-Magne [France] ; Jean-Christophe Corvol [France] ; Jean-Philippe Azulay [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Philippe Damier [France] ; Estelle Dellapina [France] ; Alain Destée [France] ; Franck Durif [France] ; Monique Galitzky [France] ; Thibaud Lebouvier [France] ; Wassilios Meissner [France] ; Claire Thalamas [France] ; François Tison [France] ; Alexandrine Salis [France] ; Agnès Sommet [France] ; François Viallet [France] ; Marie Vidailhet [France] ; Olivier Rascol [France] | Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial |
000B02 |
Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] | Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients |
000B16 |
Stéphane Palfi [France] ; Jean Marc Gurruchaga [France] ; G. Scott Ralph [Royaume-Uni] ; Helene Lepetit [France] ; Sonia Lavisse [France] ; Philip C. Buttery [Royaume-Uni] ; Colin Watts [Royaume-Uni] ; James Miskin [Royaume-Uni] ; Michelle Kelleher [Royaume-Uni] ; Sarah Deeley [Royaume-Uni] ; Hirokazu Iwamuro [France] ; Jean Pascal Lefaucheur [France] ; Claire Thiriez [France] ; Gilles Fenelon [France] ; Cherry Lucas [Royaume-Uni] ; Pierre Brugieres [France] ; Inanna Gabriel [France] ; Kou Abhay [France] ; Xavier Drouot [France] ; Naoki Tani [France] ; Aurelie Kas [France] ; Bijan Ghaleh [France] ; Philippe Le Corvoisier [France] ; Patrice Dolphin [France] ; David P. Breen [Royaume-Uni] ; Sarah Mason [Royaume-Uni] ; Natalie Valle Guzman [Royaume-Uni] ; Nicholas D. Mazarakis [Royaume-Uni] ; Pippa A. Radcliffe [Royaume-Uni] ; Richard Harrop [Royaume-Uni] ; Susan M. Kingsman [Royaume-Uni] ; Olivier Rascol [France] ; Stuart Naylor [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Pierre Cesaro [France] ; Kyriacos A. Mitrophanous [Royaume-Uni] | Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial |
000B32 |
F. Ory Magne [France] ; N. Fabre [France] ; C. Gu [France] ; C. Pastorelli [France] ; S. Tardez [France] ; J.-C. Marchat [France] ; P. Marque [France] ; C. Brefel Courbon [France] | An individual rehabilitation program: Evaluation by Parkinsonian patients and their physiotherapists |
000C08 |
Gregor K. Wenning [Autriche] ; Felix Geser [Autriche, Allemagne] ; Florian Krismer [Autriche] ; Klaus Seppi [Autriche] ; Susanne Duerr [Autriche] ; Sylvia Boesch [Autriche] ; Martin Köllensperger [Autriche] ; Georg Goebel ; Karl P. Pfeiffer [Autriche] ; Paolo Barone [Italie] ; Maria Teresa Pellecchia [Italie] ; Niall P. Quinn [Royaume-Uni] ; Vasiliki Koukouni [Royaume-Uni] ; Clare J. Fowler [Royaume-Uni] ; Anette Schrag [Royaume-Uni] ; Christopher J. Mathias [Royaume-Uni] ; Nir Giladi [Israël] ; Tanya Gurevich [Israël] ; Erik Dupont [Danemark] ; Karen Ostergaard [Danemark] ; Christer F. Nilsson [Suède] ; H Kan Widner [Suède] ; Wolfgang Oertel [Allemagne] ; Karla Maria Eggert [Allemagne] ; Alberto Albanese [Italie] ; Francesca Del Sorbo [Italie] ; Eduardo Tolosa [Espagne] ; Adriana Cardozo [Espagne] ; Günther Deuschl [Allemagne] ; Helge Hellriegel [Allemagne] ; Thomas Klockgether [Allemagne] ; Richard Dodel [Allemagne] ; Cristina Sampaio [Portugal] ; Miguel Coelho [Portugal] ; Ruth Djaldetti [Israël] ; Eldad Melamed [Israël] ; Thomas Gasser [Allemagne] ; Christoph Kamm [Allemagne] ; Giuseppe Meco [Italie] ; Carlo Colosimo [Italie] ; Olivier Rascol [France] ; Wassilios G. Meissner [France] ; François Tison [France] ; Werner Poewe [Autriche] | The natural history of multiple system atrophy: a prospective European cohort study |
000C40 |
Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Angelo Antonini [Italie] ; K. Ray Chaudhuri [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Rob M. A. De Bie [Pays-Bas] ; Günther Deuschl [Allemagne] ; Karla Eggert [Allemagne] ; Jean-Luc Houeto [France] ; Jaime Kulisevsky [Espagne] ; Dag Nyholm [Suède] ; Per Odin [Allemagne] ; Karen Stergaard [Danemark] ; Werner Poewe [Autriche] ; Pierre Pollak [Suisse] ; Jose Martin Rabey [Israël] ; Olivier Rascol [France] ; Evzen Ruzicka [République tchèque] ; Michael Samuel [Royaume-Uni] ; Hans Speelman [Pays-Bas] ; Olof Sydow [Suède] ; Francesc Valldeoriola [Espagne] ; Chris Van Der Linden [Belgique] ; Wolfgang Oertel [Allemagne] | Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review |
000C54 |
Anthony Hv Schapira [Royaume-Uni] ; Michael P. Mcdermott [États-Unis] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Stefan Albrecht [Allemagne] ; Helen H. Hsu [États-Unis] ; Daniel H. Massey [Royaume-Uni] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis] | Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial |
000C72 |
Christine Brefel-Courbon [France] ; Fabienne Ory-Magne ; Claire Thalamas ; Pierre Payoux ; Olivier Rascol | Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease. |
000C88 |
Gregory J. Tranah [États-Unis] ; Jennifer S. Yokoyama [États-Unis] ; Shana M. Katzman [États-Unis] ; Michael A. Nalls [États-Unis] ; Anne B. Newman [États-Unis] ; Tamara B. Harris [États-Unis] ; Matteo Cesari [France] ; Todd M. Manini [États-Unis] ; Nicholas J. Schork [États-Unis] ; Steven R. Cummings [États-Unis] ; Yongmei Liu [États-Unis] ; Kristine Yaffe [États-Unis] | Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African Americans |
000D09 |
Adèle Demain [France] ; G. W. Max Westby [France] ; Sara Fernandez-Vidal [France] ; Carine Karachi [France] ; Fabrice Bonneville [France] ; Manh Cuong Do [France] ; Christine Delmaire [France] ; Didier Dormont [France] ; Eric Bardinet [France] ; Yves Agid [France] ; Nathalie Chastan [France] ; Marie-Laure Welter [France] | High-level gait and balance disorders in the elderly: a midbrain disease? |
000D25 |
Olivier Rascol [France] | Extended-release carbidopa-levodopa in Parkinson's disease. |
000D32 |
P. Péran [France] ; F. Nemmi ; D. Méligne ; D. Cardebat ; A. Peppe ; O. Rascol ; C. Caltagirone ; J F Demonet ; U. Sabatini | Effect of levodopa on both verbal and motor representations of action in Parkinson's disease: a fMRI study. |
000D61 |
Céline Mias [France] ; Christelle Coatrieux [France] ; Colette Denis [France] ; Gaël Genet [France] ; Marie-Hélène Seguelas [France] ; Nathalie Laplace [France] ; Charlotte Rouzaud-Laborde [France] ; Denis Calise [France] ; Angelo Parini [France] ; Daniel Cussac [France] ; Atul Pathak [France] ; Jean-Michel Sénard [France] ; Céline Galés [France] | Cardiac Fibroblasts Regulate Sympathetic Nerve Sprouting and Neurocardiac Synapse Stability |
000D94 |
Stephan Klebe [France, Allemagne] ; Jean-Louis Golmard [France] ; Michael A. Nalls [États-Unis] ; Mohamad Saad [France] ; Andrew B. Singleton [États-Unis] ; Jose M. Bras [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Javier Simon-Sanchez [États-Unis, Pays-Bas] ; Peter Heutink [Pays-Bas] ; Gregor Kuhlenb Umer [Allemagne] ; Rim Charfi [France, Tunisie] ; Christine Klein [Allemagne] ; Johann Hagenah [Allemagne] ; Thomas Gasser [Allemagne] ; Isabel Wurster [Allemagne] ; Suzanne Lesage [France] ; Delia Lorenz [Allemagne] ; Günther Deuschl [Allemagne] ; Franck Durif [France] ; Pierre Pollak [France] ; Philippe Damier [France] ; François Tison [France] ; Alexandra Durr [France] ; Philippe Amouyel [France] ; Jean-Charles Lambert [France] ; Christophe Tzourio [France] ; Cécilia Maubaret [France] ; Fanny Charbonnier-Beaupel [France] ; Khadija Tahiri [France] ; Marie Vidailhet [France] ; Maria Martinez [France] ; Alexis Brice [France] ; Jean-Christophe Corvol [France] ; Yves Agid [France] ; M. Anheim ; A-M Bonnet ; M. Borg ; A. Brice ; E. Broussolle ; J-C Corvol ; Ph. Damier ; A. Destée ; A. Durr ; F. Durif ; S. Klebe ; E. Lohmann ; M. Martinez ; C. Penet ; P. Pollak ; P. Krack ; O. Rascol ; F. Tison ; C. Tranchant ; M. Vérin ; F. Viallet ; Vincent Plagnol ; Jose M. Bras ; Dena G. Hernandez ; Manu Sharma ; Una-Marie Sheerin ; Mohamad Saad ; Javier Sim N-Sánchez ; Claudia Schulte ; Suzanne Lesage ; Sigurlaug Sveinbjörnsd Ttir ; Philippe Amouyel ; Sampath Arepalli ; Gavin Band ; Roger A. Barker ; Céline Bellinguez ; Yoav Ben-Shlomo ; Henk W. Berendse ; Daniela Berg ; Kailash Bhatia ; Rob Ma De Bie ; Alessandro Biffi ; Bas Bloem ; Zoltan Bochdanovits ; Michael Bonin ; Kathrin Brockmann ; Janet Brooks ; David J. Burn ; Gavin Charlesworth ; Honglei Chen ; Patrick F. Chinnery ; Sean Chong ; Carl E. Clarke ; Mark R. Cookson ; J Mark Cooper ; Jean Christophe Corvol ; Carl Counsell ; Philippe Damier ; Jean-François Dartigues ; Panos Deloukas ; David T. Dexter ; Karin D. Van Dijk ; Allissa Dillman ; Frank Durif ; Sarah Edkins ; Jonathan R. Evans ; Thomas Foltynie ; Colin Freeman ; Jianjun Gao ; Michelle Gardner ; Raphael Gibbs ; Alison Goate ; Emma Gray ; Rita Guerreiro ; Mar Gústafsson ; Clare Harris ; Garrett Hellenthal ; Jacobus J. Van Hilten ; Albert Hofman ; Albert Hollenbeck ; Janice Holton ; Michele Hu ; Xuemei Huang ; Heiko Huber ; Gavin Hudson ; Sarah E. Hunt ; Johanna Huttenlocher ; Thomas Illig ; Pálmi V. J Nsson ; Cordelia Langford ; Andrew Lees ; Peter Lichtner ; Patricia Limousin ; Grisel Lopez ; Delia Lorenz ; Alisdair Mcneill ; Catriona Moorby ; Huw Morris ; Karen E. Morrison ; Ese Mudanohwo ; Sean S. O'Sullivan ; Justin Pearson ; Richard Pearson ; Joel S. Perlmutter ; Hjörvar Pétursson ; Matti Pirinen ; Pierre Pollak ; Bart Post ; Simon Potter ; Bernard Ravina ; Tamas Revesz ; Olaf Riess ; Fernando Rivadeneira ; Patrizia Rizzu ; Mina Ryten ; Stephen Sawcer ; Anthony Schapira ; Hans Scheffer ; Karen Shaw ; Ira Shoulson ; Ellen Sidransky ; Rohan De Silva ; Colin Smith ; Chris Ca Spencer ; Hreinn Stefánsson ; Stacy Steinberg ; Joanna D. Stockton ; Amy Strange ; Zhan Su ; Kevin Talbot ; Carlie M. Tanner ; Avazeh Tashakkori-Ghanbaria ; François Tison ; Daniah Trabzuni ; Bryan J. Traynor ; G. Uitterlinden ; Jana Vandrovcova ; Daan Velseboer ; Marie Vidailhet ; Damjan Vukcevic ; Robert Walker ; Bart Van De Warrenburg ; Michael E. Weale ; Mirdhu Wickremaratchi ; Nigel Williams ; Caroline H. Williams-Gray ; Sophie Winder-Rhodes ; Maria Martinez ; Peter Donnelly ; John Hardy ; Peter Heutink ; Alexis Brice ; Thomas Gasser ; Nicholas W. Wood ; Andrew B. Singleton | The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism |
000D98 |
Kathryn N. Parkinson [Royaume-Uni] ; Heather O. Dickinson [Royaume-Uni] ; Catherine Arnaud [France] ; Alan Lyons [Irlande (pays)] ; Allan Colver [Royaume-Uni] ; Eva Beckung ; Jackie Parkes ; Jérôme Fauconnier ; Alan Lyons ; Susan Michelsen ; Marco Marcelli ; Catherine Arnaud ; Ute Thyen ; Marion Rapp | Pain in young people aged 13 to 17 years with cerebral palsy: cross-sectional, multicentre European study |
000E05 |
Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Kathryn A. Chung [États-Unis] ; Robert A. Hauser [États-Unis] ; Janis M. Miyasaki [Canada] ; Anthony P. Nicholas [États-Unis] ; Werner Poewe [Autriche] ; Klaus Seppi [Autriche] ; Olivier Rascol [France] ; Mark A. Stacy [États-Unis] ; John G. Nutt [États-Unis] ; Caroline M. Tanner [États-Unis] ; Alison Urkowitz [États-Unis] ; Jean A. Jaglin [États-Unis] ; Song Ge [États-Unis] | Which dyskinesia scale best detects treatment response? |
000E10 |
Anthony E. Lang [Canada] ; Eldad Melamed [Israël] ; Werner Poewe [Autriche] ; Olivier Rascol [France] | Trial designs used to study neuroprotective therapy in Parkinson's disease |
000E17 |
Jérôme Chave [France] | The problem of pattern and scale in ecology: what have we learned in 20 years? |
000E24 |
J. J. Ferreira [Portugal] ; R. Katzenschlager [Autriche] ; B. R. Bloem [Pays-Bas] ; U. Bonuccelli [Italie] ; D. Burn [Royaume-Uni] ; G. Deuschl [Allemagne] ; E. Dietrichs [Norvège] ; G. Fabbrini [Italie] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; V. Kostic [Serbie] ; A. Nieuwboer [Belgique] ; P. Odin [Allemagne, Suède] ; Werner Poewe [Autriche] ; O. Rascol [France] ; C. Sampaio [Portugal] ; M. Schüpbach [France, Suisse] ; E. Tolosa [Espagne] ; C. Trenkwalder [Allemagne] ; A. Schapira [Royaume-Uni] ; A. Berardelli [Italie] ; W. H. Oertel [Allemagne] | Summary of the recommendations of the EFNS/MDS‐ES review on therapeutic management of Parkinson's disease |
000E25 |
A. H. V. Schapira [Royaume-Uni] ; P. Barone [Italie] ; R. A. Hauser [États-Unis] ; Y. Mizuno [Japon] ; O. Rascol [France] ; M. Busse [Allemagne] ; C. Debieuvre [France] ; M. Fraessdorf [Allemagne] ; Werner Poewe [Autriche] | Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease |
000E41 |
Paul-Etienne Mallet [France] ; Chantal Claud [France] ; Christophe Cassou [France] ; Gunnar Noer [Norvège] ; Kunihiko Kodera [Japon] | Polar lows over the Nordic and Labrador Seas: Synoptic circulation patterns and associations with North Atlantic‐Europe wintertime weather regimes |
000E42 |
Olivier Rascol [France] | Physical exercise in Parkinson disease: Moving toward more robust evidence? |
000E44 |
A. H. V. Schapira [Royaume-Uni] ; P. Barone [Italie] ; R. A. Hauser [États-Unis] ; Y. Mizuno [Japon] ; O. Rascol [France] ; M. Busse [Allemagne] ; C. Debieuvre [France] ; M. Fraessdorf [Allemagne] ; Werner Poewe [Autriche] | Patient‐reported convenience of once‐daily versus three‐times‐daily dosing during long‐term studies of pramipexole in early and advanced Parkinson’s disease |
000E80 |
C. Warren Olanow [États-Unis, Italie] ; Karl Kieburtz [États-Unis] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Anthony H. Schapira [Royaume-Uni] ; Murat Emre [Turquie] ; Helena Nissinen [Finlande] ; Mika Leinonen [Suède] ; Fabrizio Stocchi [Italie] | Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease |
000F15 |
Marie-Laure Laroche [France] ; Marie-Christine Perault-Pochat [France] ; Isabelle Ingrand [France] ; Louis Merle [France] ; Carmen Kreft-Jais [France] ; Anne Castot-Villepelet [France] ; Geneviève Durrieu [France] ; Valérie Gras [France] ; Claire Guy [France] ; Marie-Josèphe Jean-Pastor [France] ; Annie-Pierre Jonville-Béra [France] ; Isabelle Merlet-Chicoine [France] ; Ghada Miremont-Salamé [France] ; Fati Nourhashemi [France] ; Jean-Pierre Charmes [France] | Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross‐sectional study |
000F16 |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Alain Destée [France] ; Nobutaka Hattori [Japon] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Werner Poewe [Autriche] ; Mark Stacy [États-Unis] ; Eduardo Tolosa [Espagne] ; Haitao Gao [États-Unis] ; Jennifer Nagel [Suisse] ; Martin Merschhemke [Suisse] ; Ana Graf [Suisse] ; Christopher Kenney [États-Unis] ; Claudia Trenkwalder [Allemagne] | AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study |
000F27 |
V. Phe [France] ; R. Caremel [France] ; S. Bart [France] ; E. Castel-Lacanal [France] ; M. De Seze [France] ; F. Duchene [France] ; A. Even [France] ; X. Game [France] ; M. Loubat [France] ; M. C. Scheiber Nogueira [France] ; G. Karsenty [France] | Troubles vésicosphinctériens des syndromes parkinsoniens: une revue du comité de neuro-urologie de l'Association française d'urologie |
000F32 |
Jean-Pierre Jacus [France] ; Sophie Bayard [France] ; Stéphane Raffard [France] ; Marie-Christine Gely-Nargeot [France] | Prise de décision dans le vieillissement normal et pathologique : Prise de décision |
000F53 |
Santiago Perez-Lloret [France, Argentine] ; Maria Veronica Rey [France] ; Pietro Lucca Ratti [France] ; Olivier Rascol [France] | Rotigotine transdermal patch for the treatment of Parkinson's Disease |
000F76 |
P. Peran [France, Italie] ; F. Nemmi [Italie] ; D. Meligne [France] ; D. Cardebat [France] ; A. Peppe [Italie] ; O. Rascol [France] ; C. Caltagirone [Italie] ; J. F. Demonet [Suisse] ; U. Sabatini [Italie] | Effect of levodopa on both verbal and motor representations of action in Parkinson's disease: A fMRI study |
001047 |
Jean-Pierre Jacus [France] ; Sophie Bayard ; Stéphane Raffard ; Soizic Bonnoron ; Marie-Christine Gély-Nargeot | [Decision-making in normal and pathological aging]. |
001048 |
Jean-Michel Senard [France] ; Fabien Despas ; Atul Pathak | [Central autonomic failures]. |
001089 |
O. Rascol [France] ; J. Bronzova ; R A Hauser ; A E Lang ; C. Sampaio ; A. Theeuwes ; S V Van De Witte | Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial. |
001144 |
Estelle Dellapina [France] ; Fabienne Ory-Magne ; Wafa Regragui ; Claire Thalamas ; Yves Lazorthes ; Olivier Rascol ; Pierre Payoux ; Christine Brefel-Courbon | Effect of subthalamic deep brain stimulation on pain in Parkinson's disease. |
001154 |
Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Nelly Fabre ; Fabienne Ory ; Umberto Spampinato ; Jean-Louis Montastruc ; Olivier Rascol | Do Parkinson's disease patients disclose their adverse events spontaneously? |
001163 |
Javier Sim N-Sánchez [Pays-Bas] ; Laura L. Kilarski [Royaume-Uni] ; Michael A. Nalls [États-Unis] ; Maria Martinez [France] ; Claudia Schulte [Allemagne] ; Peter Holmans [Royaume-Uni] ; Thomas Gasser [Allemagne] ; John Hardy [Royaume-Uni] ; Andrew B. Singleton [États-Unis] ; Nicholas W. Wood [Royaume-Uni] ; Alexis Brice [France] ; Peter Heutink [Pays-Bas] ; Nigel Williams [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] | Cooperative Genome-Wide Analysis Shows Increased Homozygosity in Early Onset Parkinson's Disease |
001165 |
Christina M. Lill [Allemagne, États-Unis] ; Johannes T. Roehr [Allemagne] ; Matthew B. Mcqueen [États-Unis] ; Fotini K. Kavvoura [Grèce, Royaume-Uni] ; Sachin Bagade [États-Unis] ; Brit-Maren M. Schjeide [Allemagne] ; Leif M. Schjeide [Allemagne] ; Esther Meissner [Allemagne] ; Ute Zauft [Allemagne] ; Nicole C. Allen [États-Unis] ; Tian Liu [Allemagne] ; Marcel Schilling [Allemagne] ; Kari J. Anderson [États-Unis] ; Gary Beecham [États-Unis] ; Daniela Berg [Allemagne] ; Joanna M. Biernacka [États-Unis] ; Alexis Brice [France] ; Anita L. Destefano [États-Unis] ; Chuong B. Do [États-Unis] ; Nicholas Eriksson [États-Unis] ; Stewart A. Factor [États-Unis] ; Matthew J. Farrer [Canada] ; Tatiana Foroud [États-Unis] ; Thomas Gasser [Allemagne] ; Taye Hamza [États-Unis] ; John A. Hardy [Royaume-Uni] ; Peter Heutink [Pays-Bas] ; Erin M. Hill-Burns [États-Unis] ; Christine Klein [Allemagne] ; Jeanne C. Latourelle [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Eden R. Martin [États-Unis] ; Maria Martinez [France] ; Richard H. Myers [États-Unis] ; Michael A. Nalls [États-Unis] ; Nathan Pankratz [États-Unis] ; Haydeh Payami [États-Unis] ; Wataru Satake [Japon] ; William K. Scott [États-Unis] ; Manu Sharma [Allemagne] ; Andrew B. Singleton [États-Unis] ; Kari Stefansson [Islande] ; Tatsushi Toda [Japon] ; Joyce Y. Tung [États-Unis] ; Jeffery Vance [États-Unis] ; Nick W. Wood [Royaume-Uni] ; Cyrus P. Zabetian [États-Unis] ; Peter Young [Allemagne] ; Rudolph E. Tanzi [États-Unis] ; Muin J. Khoury [États-Unis] ; Frauke Zipp [Allemagne] ; Hans Lehrach [Allemagne] ; John P. A. Ioannidis [Grèce, États-Unis] ; Lars Bertram [Allemagne, États-Unis] | Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database |
001166 |
Nadège Costa [France] ; Laura Ferlicoq [France] ; Hélène Derumeaux-Burel [France] ; Thomas Rapp [France] ; Valérie Garnault [France] ; Sophie Gillette-Guyonnet [France] ; Sandrine Andrieu [France] ; Bruno Vellas [France] ; Michel Lamure [France] ; Alain Grand [France] ; Laurent Molinier [France] | Comparison of Informal Care Time and Costs in Different Age-Related Dementias: A Review |
001185 |
O. Zaberca [France] ; F. Oftinger [France] ; J Y Chane-Ching [France] ; L. Datas [France] ; A. Lafond [France] ; P. Puech [France] ; A. Balocchi [France] ; D. Lagarde [France] ; X. Marie [France] | Surfactant-free CZTS nanoparticles as building blocks for low-cost solar cell absorbers |
001199 |
Florian Mittag [Allemagne] ; Finja Büchel [Allemagne] ; Mohamad Saad [France] ; Andreas Jahn [Allemagne] ; Claudia Schulte [Allemagne] ; Zoltan Bochdanovits [Pays-Bas] ; Javier Sim N-Sánchez [Pays-Bas] ; Mike A. Nalls [États-Unis] ; Margaux Keller [États-Unis] ; Dena G. Hernandez [États-Unis, Royaume-Uni] ; J. Raphael Gibbs [États-Unis, Royaume-Uni] ; Suzanne Lesage [France] ; Alexis Brice [France] ; Peter Heutink [Pays-Bas] ; Maria Martinez [France] ; Nicholas W. Wood [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Andrew B. Singleton [États-Unis] ; Andreas Zell [Allemagne] ; Thomas Gasser [Allemagne] ; Manu Sharma [Allemagne] | Use of support vector machines for disease risk prediction in genome‐wide association studies: Concerns and opportunities |
001209 |
John Mansfield [Royaume-Uni] ; Stephane Genin [France] ; Shimpei Magori [États-Unis] ; Vitaly Citovsky [États-Unis] ; Malinee Sriariyanum [États-Unis] ; Pamela Ronald [États-Unis] ; Max Dow [Irlande (pays)] ; Valérie Verdier [France] ; Steven V. Beer [États-Unis] ; Marcos A. Machado [Brésil] ; Ian Toth [Royaume-Uni] ; George Salmond [Royaume-Uni] ; Gary D. Foster [Royaume-Uni] | Top 10 plant pathogenic bacteria in molecular plant pathology |
001242 |
Andrew Lees [Royaume-Uni] ; Stanley Fahn [États-Unis] ; Karla M. Eggert [Allemagne] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; Federico Micheli [Argentine] ; M. Maral Mouradian [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Eduardo Tolosa [Espagne] ; David Squillacote [États-Unis] ; Dinesh Kumar [États-Unis] | Perampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson's disease |
001245 |
S. Perez-Lloret [France, Argentine] ; L. Nègre-Pagès [France] ; A. Ojero-Senard [France] ; P. Damier ; A. Destée ; F. Tison [France] ; M. Merello [Argentine] ; O. Rascol [France] | Oro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort |
001249 |
Thomas Besnard [France] ; Christel Vaché [France] ; David Baux [France] ; Lise Larrieu [France] ; Caroline Abadie [France] ; Catherine Blanchet [France] ; Sylvie Odent [France] ; Patricia Blanchet [France] ; Patrick Calvas [France] ; Christian Hamel [France] ; Hélène Dollfus [France] ; Geneviève Lina-Granade [France] ; James Lespinasse [France] ; Albert David [France] ; Bertrand Isidor [France] ; Gilles Morin [France] ; Sue Malcolm [Royaume-Uni] ; Sylvie Tuffery-Giraud [France] ; Mireille Claustres [France] ; Anne-Françoise Roux [France] | Non‐USH2A mutations in USH2 patients |
001252 |
T. Billoux [France] ; Y. Cressault [France] ; V F Boretskij [Ukraine] ; A N Veklich [Ukraine] ; A. Gleizes [France] | Net emission coefficient of CO-Cu thermal plasmas: role of copper and molecules. |
001325 |
Olivier Rascol [France] ; Joaquim Ferreira [Portugal] ; Laurence Nègre-Pages [France] ; Santiago Perez-Lloret [France] ; Lucette Lacomblez [France] ; Monique Galitzky [France] ; Jean-Christophe Lemarié [France] ; Jean-Christophe Corvol [France] ; Jonathan M. Brotchie [Canada] ; Laura Bossi [France] | A proof‐of‐concept, randomized, placebo‐controlled, multiple cross‐overs (n‐of‐1) study of naftazone in Parkinson’s disease |
001355 |
Jean-Pierre Jacus [France] ; Sophie Bayard [France] ; Stéphane Raffard [France] ; Soizic Bonnoron [France] ; Marie-Christine Gely-Nargeot [France] | Prise de décision dans le vieillissement normal et pathologique |
001377 |
Jean-Michel Senard [France] ; Fabien Despas [France] ; Atul Pathak [France] | Dysautonomies centrales : Hypotension orthostatique |
001390 |
Margaux F. Keller [États-Unis] ; Mohamad Saad [France] ; Jose Bras [Royaume-Uni] ; Francesco Bettella [Islande] ; Nayia Nicolaou [Pays-Bas] ; Javier Simon-Sanchez [Pays-Bas] ; Florian Mittag [France] ; Finja Büchel [France] ; Manu Sharma [Allemagne] ; J. Raphael Gibbs [États-Unis, Royaume-Uni] ; Claudia Schulte [Allemagne] ; Valentina Moskvina [Royaume-Uni] ; Alexandra Durr [France] ; Peter Holmans [Royaume-Uni] ; Laura L. Kilarski [Royaume-Uni] ; Rita Guerreiro [Royaume-Uni] ; Dena G. Hernandez [États-Unis, Royaume-Uni] ; Alexis Brice [France] ; Pauli Ylikotila [Finlande] ; Hreinn Stefansson [Islande] ; Kari Majamaa [Finlande] ; Huw R. Morris [Royaume-Uni] ; Nigel Williams [Royaume-Uni] ; Thomas Gasser [Allemagne] ; Peter Heutink [Islande] ; Nicholas W. Wood [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Maria Martinez [France] ; Andrew B. Singleton [États-Unis] ; Michael A. Nalls [États-Unis] | Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease |
001414 |
S. Lesage [France] ; C. Condroyer [France] ; S. Klebe [France] ; A. Honore [France] ; F. Tison [France] ; C. Brefel-Courbon [France] ; A. Diirr [France] ; A. Brice [France] | IDENTIFICATION OF VPS35 MUTATIONS REPLICATED IN FRENCH FAMILIES WITH PARKINSON DISEASE |
001425 |
Estelle Dellapina [France] ; Fabienne Ory-Magne [France] ; Wafa Regragui [France] ; Claire Thalamas [France] ; Yves Lazorthes [France] ; Olivier Rascal [France] ; Pierre Payoux [France] ; Christine Brefel-Courbon [France] | Effect of subthalamic deep brain stimulation on pain in Parkinson's disease |
001430 |
Santiago Perez-Lloret [France] ; Maria Veronica Rey [France] ; Nelly Fabre [France] ; Fabienne Ory [France] ; Umberto Spampinato [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] | Do Parkinson's disease patients disclose their adverse events spontaneously? |
001517 |
M. Roumiguié [France] ; J. Guillotreau ; E. Castel-Lacanal ; B. Malavaud ; X. De Boissezon ; P. Marque ; P. Rischmann ; X. Gamé | [Assessment of sexual function in men with idiopathic Parkinson's disease using the International Index of Erectile Dysfunction (IIEF-15)]. |
001539 |
Santiago Perez-Lloret [France] ; Olivier Rascol | Safety of rasagiline for the treatment of Parkinson's disease. |
001545 |
Santiago Perez-Lloret [France] ; Santiago Perez Lloret ; María Ver Nica Rey ; Luca Ratti ; Olivier Rascol | Pramipexole for the treatment of early Parkinson's disease. |
001549 |
Santiago Perez Lloret ; Malco Rossi [Argentine] ; Marcelo Merello [Argentine] ; Olivier Rascol [France] ; Daniel P. Cardinali | Nonmotor Symptoms Groups in Parkinson's Disease Patients: Results of a Pilot, Exploratory Study |
001563 |
Eric Bui [France] ; Julien Delrieu ; Thomas Wagner ; Julie Rieu ; Etienne Véry ; Clara Letamendia ; Pierre Payoux ; Laurent Schmitt | Iodine-123 fluoropropyl-carbomethoxy-3-β-(4-iodophenyltropane) single-photon emission computed tomography findings before and after electroconvulsive therapy in major depressive disorder with Parkinsonism. |
001577 |
Mohamad Saad [France] ; Suzanne Lesage ; Aude Saint-Pierre ; Jean-Christophe Corvol ; Diana Zelenika ; Jean-Charles Lambert ; Marie Vidailhet ; George D. Mellick ; Ebba Lohmann ; Franck Durif ; Pierre Pollak ; Philippe Damier ; François Tison ; Peter A. Silburn ; Christophe Tzourio ; Sylvie Forlani ; Marie-Anne Loriot ; Maurice Giroud ; Catherine Helmer ; Florence Portet ; Philippe Amouyel ; Mark Lathrop ; Alexis Elbaz ; Alexandra Durr ; Maria Martinez ; Alexis Brice | Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. |
001596 |
Michelle K. Lupton [Royaume-Uni] ; Petroula Proitsi [Royaume-Uni] ; Makrina Danillidou [Grèce] ; Magda Tsolaki [Grèce] ; Gillian Hamilton [Royaume-Uni] ; Richard Wroe [Royaume-Uni] ; Megan Pritchard [Royaume-Uni] ; Kathryn Lord [Royaume-Uni] ; Belinda M. Martin [Royaume-Uni] ; Iwona Kloszewska [Pologne] ; Hilkka Soininen [Finlande] ; Patrizia Mecocci [Italie] ; Bruno Vellas [France] ; Denise Harold [Royaume-Uni] ; Paul Hollingworth [Royaume-Uni] ; Simon Lovestone [Royaume-Uni] ; John F. Powell [Royaume-Uni] | Deep Sequencing of the Nicastrin Gene in Pooled DNA, the Identification of Genetic Variants That Affect Risk of Alzheimer's Disease |
001625 |
Olivier Rascol [France] ; Cheryl J. Fitzer-Attas ; Robert Hauser ; Joseph Jankovic [États-Unis] ; Anthony Lang ; J William Langston ; Eldad Melamed ; Werner Poewe [Autriche] ; Fabrizio Stocchi ; Eduardo Tolosa ; Eli Eyal ; Yoni M. Weiss ; C Warren Olanow | A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. |
001637 |
Marieke Longcamp [Finlande, France] ; Yevhen Hlushchuk [Finlande] ; Riitta Hari [Finlande] | What differs in visual recognition of handwritten vs. printed letters? An fMRI study |
001638 |
Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ray K. Chaudhuri [Royaume-Uni] ; Marcelo Merello [Argentine] ; Robert Hauser [États-Unis] ; Regina Katzenschlager [Autriche] ; Per Odin [Allemagne] ; Mark Stacy [États-Unis] ; Fabrizio Stocchi [Italie] ; Werner Poewe [Autriche] ; Oliver Rascol [France] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Wearing‐off scales in Parkinson's disease: Critique and recommendations |
001646 |
Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease |
001647 |
Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease |
001657 |
Arnaud Blanchard [France] ; Agathe Roubertie [France] ; Marion Simonetta-Moreau [France] ; Vuthy Ea [France] ; Coline Coquart [France] ; Melissa Y. Frederic [France] ; Gael Gallouedec [France] ; Jean-Paul Adenis [France] ; Isabelle Benatru [France] ; Michel Borg [France] ; Pierre Burbaud [France] ; Patrick Calvas [France] ; Laura Cif [France] ; Philippe Damier [France] ; Alain Destée [France] ; Laurence Faivre [France] ; Lucie Guyant-Marechal [France] ; Piotr Janik [Pologne] ; Samer Janoura [France] ; Alexandre Kreisler [France] ; Anna Lusakowska [Pologne] ; Sylvie Odent [France] ; Anna Potulska-Chromik [Pologne] ; Monika Rudzi Ska [Pologne] ; Stephane Thobois [France] ; Isabelle Vuillaume [France] ; Christine Tranchant [France] ; Sylvie Tuffery-Giraud [France] ; Philippe Coubes [France] ; Bernard Sablonnière [France] ; Mireille Claustres [France] ; Gwenaelle Collod-Béroud [France] | Singular DYT6 phenotypes in association with new THAP1 frameshift mutations |
001658 |
Julia Grossac [France] ; Stéphanie Ruiz [France] ; Emmanuelle Bondon-Guitton [France] ; Franck-Emmanuel Roux [France] ; Olivier Fourcade [France] ; Jean-Louis Montastruc [France] ; Thomas Geeraerts [France] | Severe intracranial bleeding related to vitamin K Antagonist‐Ropinirole interaction |
001664 |
Julien Delrieu [France] ; Pierre Payoux [France] ; Thierry Voisin [France] | Reply: Sensory alien limb syndrome in stroke and corticobasal syndrome |
001671 |
Wassilios G. Meissner [France] ; Mark Frasier [États-Unis] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Andres Lozano [Canada] ; Paola Piccini [Royaume-Uni] ; José A. Obeso [Espagne] ; Olivier Rascol [France] ; Anthony Schapira [Royaume-Uni] ; Valerie Voon [Royaume-Uni] ; David M. Weiner [États-Unis] ; François Tison [France] ; Erwan Bezard [France] | Priorities in Parkinson's disease research |
001674 |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
001684 |
Monique Seyler [France] ; Daniele Brunelli [Italie, France] ; Michael J. Toplis [France] ; Catherine Mével [France] | Multiscale chemical heterogeneities beneath the eastern Southwest Indian Ridge (52°E–68°E): Trace element compositions of along‐axis dredged peridotites |
001689 |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
001704 |
P. Rampal [États-Unis, France] ; J. Weiss [France] ; C. Dubois [France] ; J. Campin [États-Unis] | IPCC climate models do not capture Arctic sea ice drift acceleration: Consequences in terms of projected sea ice thinning and decline |
001708 |
Pablo Martinez-Martin [Espagne] ; Martine Jeukens-Visser [Pays-Bas] ; Kelly E. Lyons [États-Unis] ; C. Rodriguez-Blazquez [Espagne] ; Caroline Selai [Royaume-Uni] ; Andrew Siderowf [États-Unis] ; Mickie Welsh [États-Unis] ; Werner Poewe [Autriche] ; Oliver Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anette Schrag [Royaume-Uni] | Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations |
001712 |
Agathe Germe [France] ; Marie-Noëlle Houssais [France] ; Christophe Herbaut [France] ; Christophe Cassou [France] | Greenland Sea sea ice variability over 1979–2007 and its link to the surface atmosphere |
001722 |
Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France |
001723 |
O. Rascol [France] | Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged‐release |
001735 |
T. R. Jaffe [France] ; A. J. Banday [France, Allemagne] ; J. P. Leahy [France] ; S. Leach [Italie, France] ; A. W. Strong [Allemagne, France] | Connecting synchrotron, cosmic rays and magnetic fields in the plane of the Galaxy |
001740 |
Jorge A. R. Salvador [Portugal] ; Vânia M. Moreira [Portugal] ; Rui M. A. Pinto ; Ana S. Leal ; Christophe Le Roux [France] | Bismuth(III) Triflate‐Based Catalytic Direct Opening of Oleanolic Hydroxy‐γ‐lactones to Afford 12‐Oxo‐28‐carboxylic Acids |
001745 |
Estelle Dellapina [France] ; Angélique Gerdelat-Mas [France] ; Fabienne Ory-Magne [France] ; Laure Pourcel [France] ; Monique Galitzky [France] ; Fabienne Calvas [France] ; Marion Simonetta-Moreau [France] ; Claire Thalamas [France] ; Pierre Payoux [France] ; Christine Brefel-Courbon [France] | Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study |
001755 |
Shilpa Kumar-Roiné [France] ; H. Taiana Darius [Polynésie française] ; Mariko Matsui [France] ; Nicolas Fabre [France] ; Mohamed Haddad [France] ; Mireille Chinain [Polynésie française] ; Serge Pauillac ; Dominique Laurent [France] | A Review of Traditional Remedies of Ciguatera Fish Poisoning in the Pacific |
001760 |
M. Roumiguie [France] ; J. Guillotreau [France] ; E. Castel-Lacanal [France] ; B. Malavaud [France] ; X. De Boissezon [France] ; P. Marque [France] ; P. Rischmann [France] ; X. Game [France] | Évaluation par l'index international de la fonction érectile (IIEF-15) de la fonction sexuelle des hommes atteints d'une maladie de Parkinson idiopathique |
001782 |
Michel Laroche [France] | La camptocormie du sujet âgé |
001801 |
Valérie Cochen De Cock [France] ; Rachel Debs [France] ; Delphine Oudiette [France] ; Smaranda Leu [France] ; Fatai Radji [France] ; Michel Tiberge [France] ; HUAN YU [France, République populaire de Chine] ; Sophie Bayard [France] ; Emmanuel Roze [France] ; Marie Vidailhet [France] ; Yves Dauvilliers [France] ; Olivier Rascol [France] ; Isabelle Arnulf [France] | The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy |
001810 |
C. Annweiler [France] ; Y. Rolland [France] ; A. M. Schott [France] ; H. Blain [France] ; B. Vellas [France] ; O. Beauchet [France] | Serum Vitamin D Deficiency as a Predictor of Incident Non-Alzheimer Dementias: A 7-Year Longitudinal Study |
001829 |
Eric Bui [France] ; Julien Delrieu [France] ; Thomas Wagner [France] ; Julie Rieu [France] ; Etienne Very [France] ; Clara Letamendia [France] ; Pierre Payoux [France] ; Laurent Schmitt [France] | Iodine-123 Fluoropropyl-Carbomethoxy-3-β-(4-lodophenyltropane) Single-Photon Emission Computed Tomography Findings Before and After Electroconvulsive Therapy in Major Depressive Disorder With Parkinsonism |
001833 |
Pablo Martinez-Martin [Espagne] ; Martine Jeukens-Visser [Pays-Bas] ; Kelly E. Lyons [États-Unis] ; C. Rodriguez-Blazquez [Espagne] ; Caroline Selai [Royaume-Uni] ; Andrew Siderowf [États-Unis] ; Mickie Welsh [États-Unis] ; Werner Poewe [Autriche] ; Oliver Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anette Schrag [Royaume-Uni] | Health-Related Quality-of-Life Scales in Parkinson's Disease: Critique and Recommendations |
001836 |
Mohamad Saad [France] ; Suzanne Lesage [France] ; Aude Saint-Pierre [France] ; Jean-Christophe Corvol [France] ; Diana Zelenika [France] ; Jean-Charles Lambert [France] ; Marie Vidailhet [France] ; George D. Mellick [Australie] ; Ebba Lohmann [France] ; Franck Durif [France] ; Pierre Pollak [France] ; Philippe Damier [France] ; François Tison [France] ; Peter A. Silburn [Australie] ; Christophe Tzourio [France] ; Sylvie Foriani [France] ; Marie-Anne Loriot [France] ; Maurice Giroud [France] ; Catherine Helmer [France] ; Florence Portet [France] ; Philippe Amouyel [France] ; Mark Lathrop [France] ; Alexis Elbaz [France] ; Alexandra Durr [France] ; Maria Martinez [France] ; Alexis Brice [France] | Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population |
001838 |
Werner Poewe [Autriche] ; O. Rascol [France] ; P. Barone [Italie] ; R. A. Hauser [États-Unis] ; Y. Mizuno ; M. Haaksma ; L. Salin ; N. Juhel ; A. H. V. Schapira | Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial |
001839 |
A. H. V. Schapira [Royaume-Uni] ; P. Barone [Italie] ; R. A. Hauser [États-Unis] ; Y. Mizuno [Japon] ; O. Rascol [France] ; M. Busse [Allemagne] ; L. Salin [France] ; N. Juhel [France] ; Werner Poewe [Autriche] | Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial |
001840 |
Claudia Moreno-Lopez [Espagne] ; Joan Santamaria [Espagne] ; Manuel Salamero [Espagne] ; Francesca Del Sorbo [Italie] ; Alberto Albanese [Italie] ; Maria Teresa Pellecchia [Italie] ; Paolo Barone [Italie] ; Sebastiaan Overeem ; Bastiaan Bloem [Pays-Bas] ; Willemijn Aarden [Pays-Bas, Italie] ; Margherita Canesi [Italie] ; Angelo Antonini ; Susanne Duerr [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche] ; Alfonso Rubino [Italie] ; Giuseppe Meco [Italie] ; Susanne A. Schneider [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Ruth Djaldetti [Israël] ; Miguel Coelho [Portugal] ; Cristina Sampaio [Portugal] ; Valerie Cochen [France] ; Helge Hellriegel [Allemagne] ; Gunther Deuschl [Allemagne] ; Carlo Colosimo [Italie] ; Luca Marsili [Italie] ; Thomas Gasser [Allemagne] ; Eduardo Tolosa [Espagne] | Excessive Daytime Sleepiness in Multiple System Atrophy (SLEEMSA Study) |
001845 |
Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France |
001855 |
V. Marchand-Pauvert [France] ; A. Gerdelat-Mas [France] ; F. Ory-Magne [France] ; F. Calvas [France] ; D. Mazevet [France] ; S. Meunier [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; M. Simonetta-Moreau [France] | Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease |
001975 |
Rachel Debs [France] ; Valérie Cochen De Cock ; Laurence Nègre-Pagès ; Marina Aristin ; Anna Senard ; Olivier Rascol | Thought disorders among non-demented outpatients with Parkinson's disease: prevalence and associated factors. |
001980 |
Tatyana D. Sotnikova [Italie, États-Unis] ; Jean-Martin Beaulieu [Canada] ; Stefano Espinoza [Italie] ; Bernard Masri [États-Unis, France] ; Xiaodong Zhang [Singapour] ; Ali Salahpour [États-Unis, Canada] ; Larry S. Barak [États-Unis] ; Marc G. Caron [États-Unis] ; Raul R. Gainetdinov [Italie, États-Unis] | The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator |
001998 |
Santiago Perez Lloret [France] ; Olivier Rascol | Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease. |
001A03 |
J-M Senard [France] ; A. Pathak | Neurogenic orthostatic hypotension of Parkinson's disease: what exploration for what treatment? |
001A08 |
P. Payoux [France] ; C. Brefel-Courbon ; F. Ory-Magne ; W. Regragui ; C. Thalamas ; S. Balduyck ; F. Durif ; J P Azulay ; F. Tison ; O. Blin ; J P Esquerre ; O. Rascol | Motor activation in multiple system atrophy and Parkinson disease: a PET study. |
001A38 |
Masashi Okuro [États-Unis] ; Nobuhiro Fujiki [États-Unis] ; Nozomu Kotorii [États-Unis] ; Yuji Ishimaru [États-Unis] ; Pierre Sokoloff [France] ; Seiji Nishino [États-Unis] | Effects of Paraxanthine and Caffeine on Sleep, Locomotor Activity, and Body Temperature in Orexin/Ataxin-3 Transgenic Narcoleptic Mice |
001A44 |
Santiago Perez-Lloret [France] ; Olivier Rascol | Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease. |
001A72 |
Ana G. Barbeito [États-Unis] ; Thierry Levade [France] ; Marie B. Delisle [France] ; Bernardino Ghetti [États-Unis] ; Ruben Vidal [États-Unis] | Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy |
001A89 |
Stphanie Rivire [France] ; Artus Albessard [France] ; Virginie Gardette [France] ; Karine Lapierre-Duval [France] ; Valrie Schwbel [France] ; Thierry Lang [France] | Psychosocial risk factors for depressive symptoms after the AZF chemical factory explosion in Toulouse, France |
001B10 |
Delphine Simon ; Benoit Laloo ; Malika Barillot ; Thomas Barnetche ; Camille Blanchard ; Caroline Rooryck ; Michle Marche ; Ingrid Burgelin ; Isabelle Coupry ; Nicolas Chassaing [France] ; Brigitte Gilbert-Dussardier [France] ; Didier Lacombe ; Christophe Grosset ; Benoit Arveiler [France] | A mutation in the 3-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia |
001B28 |
Carlo Colosimo [Italie] ; Pablo Martínez-Martín [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis] | Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations |
001B40 |
Joaquim J. Ferreira [Portugal] ; Dulce Neutel [Portugal] ; Tiago Mestre [Portugal] ; Miguel Coelho [Portugal] ; Mário M. Rosa [Portugal] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Skin cancer and Parkinson's disease |
001B42 |
Julien Delrieu [France] ; Pierre Payoux [France] ; Olivier Toulza [France] ; Jean-Paul Esquerre [France] ; Bruno Vellas [France] ; Thierry Voisin [France] | Sensory alien hand syndrome in corticobasal degeneration: A cerebral blood flow study |
001B43 |
Birgit Högl [Autriche] ; Isabelle Arnulf [France] ; Cynthia Comella [États-Unis] ; Joaquim Ferreira [Portugal] ; Alex Iranzo [Espagne] ; Barbara Tilley [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis] | Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations |
001B44 |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study |
001B49 |
Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis] | Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study |
001B50 |
Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
001B60 |
Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France] | Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study |
001B65 |
Jean-Louis Montastruc [France] ; Anne Charlotte Danton [France] ; Genevieve Durrieu [France] ; Isabelle Lacroix [France] ; Pascale Olivier [France] ; Agnés Sommet [France] ; Jean-Michel Senard [France] | Neuropathy as a potential complication of levodopa use in Parkinson's disease: A Pharmacological and Pharmacovigilance point of view |
001B69 |
Jean-Michel Laffosse [France] ; Thierry Odent [France] ; Franck Accadbled [France] ; Thibault Cachon [France] ; Charles Kinkpe [France] ; Eric Viguier [France] ; Jérôme Sales De Gauzy [France] ; Pascal Swider [France] | Micro‐computed tomography evaluation of vertebral end‐plate trabecular bone changes in a porcine asymmetric vertebral tether |
001B84 |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [Italie, États-Unis] | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
001B92 |
Markus Aretz [France] | Habitats of colonial rugose corals: the Mississippian of western Europe as example for a general classification |
001B98 |
Joseph H. Friedman [États-Unis] ; Guido Alves [Norvège] ; Peter Hagell [Suède] ; Johan Marinus [Pays-Bas] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] | Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease |
001C04 |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
001C09 |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
001C11 |
Sophie Gavarini [États-Unis] ; Corinne Cayrol [France] ; Tania Fuchs [États-Unis] ; Natalia Lyons [États-Unis] ; Michelle E. Ehrlich [États-Unis] ; Jean-Philippe Girard [France] ; Laurie J. Ozelius [États-Unis, France] | Direct interaction between causative genes of DYT1 and DYT6 primary dystonia |
001C28 |
Jeanmarc Dcaudin [France] ; Denis Lacoste [France] | Are services advertised differently An empirical examination |
001C29 |
Laurence Nègre-Pagès [France] ; Hélène Grandjean [France] ; Maryse Lapeyre-Mestre [France] ; Jean Louis Montastruc [France] ; Annie Fourrier [France] ; Jean Pierre Lépine [France] ; Oliver Rascol [France] | Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP study |
001C33 |
Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database |
001C36 |
K. Hurley [États-Unis] ; A. Rowlinson ; E. Bellm [États-Unis] ; D. Perley [États-Unis] ; I. G. Mitrofanov [Russie] ; D. V. Golovin [Russie] ; A. S. Kozyrev [Russie] ; M. L. Litvak [Russie] ; A. B. Sanin [Russie] ; W. Boynton [États-Unis] ; C. Fellows [États-Unis] ; K. Harshmann [États-Unis] ; M. Ohno [Japon] ; K. Yamaoka [Japon] ; Y. E. Nakagawa [Japon] ; D. M. Smith [États-Unis] ; T. Cline [États-Unis] ; N. R. Tanvir ; P. T. O'Brien ; K. Wiersema ; E. Rol [Pays-Bas] ; A. Levan ; J. Rhoads [États-Unis] ; A. Fruchter [États-Unis] ; D. Bersier ; J. J. Kavelaars [Canada] ; N. Gehrels [États-Unis] ; H. Krimm [États-Unis] ; D. M. Palmer [États-Unis] ; R. C. Duncan [États-Unis] ; C. Wigger [Suisse] ; W. Hajdas [Suisse] ; J. Atteia [France] ; G. Ricker [États-Unis] ; R. Vanderspek [États-Unis] ; A. Rau [Allemagne] ; A. Von Kienlin [Allemagne] | A new analysis of the short‐duration, hard‐spectrum GRB 051103, a possible extragalactic soft gamma repeater giant flare |
001C89 |
J.-M. Senard [France] ; A. Pathak [France] | Hypotension orthostatique neurigène dans la maladie de Parkinson: quelles explorations pour quel traitement ? |
001D31 |
P. Payoux [France] ; C. Brefel-Courbon [France] ; F. Ory-Magne [France] ; W. Regragui [France] ; C. Thalamas [France] ; S. Balduyck [France] ; F. Durif [France] ; J. P. Azulay [France] ; F. Tison [France] ; O. Blin [France] ; J. P. Esquerre [France] ; O. Rascol [France] | Motor activation in multiple system atrophy and Parkinson disease: A PET study |
001D33 |
Patrice Peran [Italie, France] ; Andrea Cherubini [Italie] ; Francesca Assogna [Italie] ; Fabrizio Piras [Italie] ; Carlo Quattrocchi [Italie] ; Antonella Peppe [Italie] ; Pierre Celsis [France] ; Olivier Rascol [France] ; Jean-François Demonet [France] ; Alessandro Stefani [Italie] ; Mariangela Pierantozzi [Italie] ; Francesco Ernesto Pontieri [Italie] ; Carlo Caltagirone [Italie] ; Gianfranco Spalletta [Italie] ; Umberto Sabatini [Italie] | Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature |
001D46 |
Santiago Perez-Lloret [France, Argentine] ; Olivier Rascol [France] | Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson's Disease |
001D58 |
Laurence Negre-Pages [France] ; Hélène Grandjean [France] ; Maryse Lapeyre-Mestre [France] ; Jean Louis Montastruc [France] ; Annie Fourrier [France] ; Jean Pierre Lepine [France] ; Oliver Rascol [France] | Anxious and Depressive Symptoms in Parkinson's Disease: The French Cross-Sectionnal DoPAMiP Study |
001D66 |
Joaquim J. Ferreira [Portugal] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; José-Francisco Rocha [Portugal] ; Teresa Nunes [Portugal] ; Luis Almeida [Portugal] ; Patrício Soares-Da-Silva [Portugal] | A Double-Blind, Randomized, Placebo and Active-Controlled Study of Nebicapone for the Treatment of Motor Fluctuations in Parkinson's Disease |
001E67 |
C. Brefel-Courbon [France] | [Digestive disturbances in Parkinson disease]. |
001E88 |
Catherine Au [États-Unis] ; Alexandre Benedetto [États-Unis, Royaume-Uni] ; Joel Anderson [États-Unis] ; Arnaud Labrousse [France] ; Keith Erikson [États-Unis] ; Jonathan J. Ewbank [France] ; Michael Aschner [États-Unis] | SMF-1, SMF-2 and SMF-3 DMT1 Orthologues Regulate and Are Regulated Differentially by Manganese Levels in C. elegans |
001E89 |
Olivier Rascol [France] ; Santiago Perez-Lloret | Rotigotine transdermal delivery for the treatment of Parkinson's disease. |
001F03 |
Patrice Péran [France] ; Dominique Cardebat ; Andrea Cherubini ; Fabrizio Piras ; Giacomo Luccichenti ; Antonella Peppe ; Carlo Caltagirone ; Olivier Rascol ; Jean-François Démonet ; Umberto Sabatini | Object naming and action-verb generation in Parkinson's disease: a fMRI study. |
001F68 |
Olivier Rascol [France] | "Disease-modification" trials in Parkinson disease: target populations, endpoints and study design. |
001F79 |
Jérôme Fauconnier [France, Royaume-Uni] ; Heather O. Dickinson [Royaume-Uni] ; Eva Beckung [Suède, Royaume-Uni] ; Marco Marcelli [Italie, Royaume-Uni] ; Vicki Mcmanus [Irlande (pays), Royaume-Uni] ; Susan I. Michelsen [Danemark, Royaume-Uni] ; Jackie Parkes [Royaume-Uni] ; Kathryn N. Parkinson [Royaume-Uni] ; Ute Thyen [Allemagne, Royaume-Uni] ; Catherine Arnaud [France, Royaume-Uni] ; Allan Colver [Royaume-Uni] | Participation in life situations of 8-12 year old children with cerebral palsy: cross sectional European study |
001F83 |
Julia Gathpresent Address Physical Chemistry Eth Zrich Wolfgang-Pauli-Strasse Ch-8093 Zurich Switzerland [France] ; Gina L. Hoaston [États-Unis] ; Robert L. Vold [États-Unis] ; Romain Berthoud [France] ; Christophe Copret [France] ; Mary Grellier [France] ; Sylviane Sabo-Etienne [France] ; Anne Lesage [France] ; Lyndon Emsley [France] | Motional heterogeneity in single-site silica-supported species revealed by deuteron NMR |
002002 |
Patrice Péran [Italie, France] ; Andrea Cherubini [Italie] ; Giacomo Luccichenti [Italie] ; Gisela Hagberg [Italie] ; Jean-François Démonet [France] ; Olivier Rascol [France] ; Pierre Celsis [France] ; Carlo Caltagirone [Italie] ; Gianfranco Spalletta [Italie] ; Umberto Sabatini [Italie] | Volume and iron content in basal ganglia and thalamus |
002014 |
Mélissa Yana Frédéric [France] ; Fabienne Clot [France] ; Arnaud Blanchard [France] ; Claire-Marie Dhaenens [France] ; Gaëtan Lesca [France] ; Laura Cif [France] ; Alexandra Dürr [France] ; Marie Vidailhet [France] ; Bernard Sablonniere [France] ; Alain Calender [France] ; Maria Martinez [France] ; Nicolas Molinari [France] ; Alexis Brice [France] ; Mireille Claustres [France] ; Sylvie Tuffery-Giraud [France] ; Gwenaëlle Collod-Beroud [France] | The p.Asp216His TOR1A allele effect is not found in the French population |
002024 |
Renaud Massart [France] ; Jean-Philippe Guilloux [France] ; Virginie Mignon [France] ; Pierre Sokoloff [France] ; Jorge Diaz [France] | Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents |
002031 |
K. Strelnikov [France] ; J. Rouger [France] ; P. Barone [France] ; O. Deguine [France] | Role of speechreading in audiovisual interactions during the recovery of speech comprehension in deaf adults with cochlear implants |
002038 |
J. Parkes [Royaume-Uni] ; M. White-Koning [France] ; N. Mccullough [Royaume-Uni] ; A. Colver [Royaume-Uni] | Psychological problems in children with hemiplegia: a European multicentre survey |
002045 |
A. H. Schapira [Royaume-Uni] ; Yves Agid [France] ; P. Barone [Italie] ; P. Jenner [Royaume-Uni] ; M. R. Lemke [Allemagne] ; Werner Poewe [Autriche] ; O. Rascol [France] ; H. Reichmann [Allemagne] ; E. Tolosa [Espagne] | Perspectives on recent advances in the understanding and treatment of Parkinson’s disease |
002054 |
Annamaria Colao ; Paolo Cappabianca [Italie] ; Philippe Caron [France] ; Ernesto De Menis [Italie] ; Andrew J. Farrall [Royaume-Uni] ; Monica R. Gadelha [Brésil] ; Abdel Hmissi [Suisse] ; Aled Rees [Royaume-Uni] ; Martin Reincke [Allemagne] ; Mitra Safari [Suisse] ; Guy T'Sjoen [Belgique] ; Hakim Bouterfa [Suisse] ; Ross C. Cuneo [Australie] | Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open‐label, multicentre study |
002060 |
S. Lesage [France] ; C. Condroyer [France] ; A. Lannuzel [France] ; E. Lohmann [France] ; A. Troiano [France] ; F. Tison [France] ; P. Damier [France] ; S. Thobois [France] ; A-M Ouvrard-Hernandez [France] ; S. Rivaud-Péchoux [France] ; C. Brefel-Courbon [France] ; A. Destée [France] ; C. Tranchant [France] ; M. Romana ; L. Leclere [France] ; A. Dürr [France] ; A. Brice [France] | Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson’s disease |
002084 |
Marian L. Evatt [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni] ; Kelvin L. Chou [États-Unis] ; Ester Cubo [Espagne] ; Vanessa Hinson [États-Unis] ; Katie Kompoliti [États-Unis] ; Chengwu Yang [États-Unis] ; Werner Poewe [États-Unis] ; Olivier Rascol [Autriche] ; Cristina Sampaio [France, Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation—Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease |
002092 |
Frédérique Sabourdy [France] ; Helen Michelakakis [Grèce] ; Aris Anastasakis [Grèce] ; Virginie Garcia [France] ; Irene Mavridou [France, Grèce] ; Michèle Nieto [France] ; Marie-Claude Pons [France, Grèce] ; Constantinos Skiadas [Grèce] ; Marina Moraitou [Grèce] ; Panagiota Manta [Grèce] ; Milan Elleder [République tchèque] ; Thierry Levade [France] | Danon disease: Further clinical and molecular heterogeneity |
002108 |
Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni] | Adherence to antiparkinson medication in a multicenter European study |
002110 |
Olivier Rascol [France] ; Ludwig Schelosky [Suisse] | 123I‐metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders |
002155 |
Pablo Ibanez [France, Royaume-Uni] ; LESAGE [France] ; Sabine Janin [France] ; Ebba Lohmann [France] ; Frank Durif [France] ; Alain Destée [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Simon Heath [France] ; Diana Zelenika [France] ; Yves Agid [France] ; Alexandra Dürr [France] ; Alexis Brice [France] | α-Synuclein Gene Rearrangements in Dominantly Inherited Parkinsonism : Frequency, Phenotype, and Mechanisms |
002162 |
Quesada-Pe Ate Isariebel [Cuba, France] ; Julcour-Lebigue Carine [France] ; Jauregui-Haza Ulises-Javier [Cuba] ; Wilhelm Anne-Marie [France] ; Delmas Henri [France] | Sonolysis of levodopa and paracetamol in aqueous solutions |
002169 |
Serge Guerreiro [France] ; Aurélie Ponceau [France] ; Damien Toulorge [France] ; Elodie Martin [France] ; Daniel Alvarez-Fischer [France] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France] | Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization |
002196 |
Pierre Payoux [France] ; Philippe Remy [France] ; Malika Miloudi [France] ; Jean-Luc Houeto [France] ; Claudio Stadler [France] ; Boulos-Paul Bejjani [France] ; Jérome Yelnik [France] ; Yves Samson [France] ; Olivier Rascol [France] ; Yves Agid [France] ; Philippe Damier [France] | Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease |
002197 |
Christine Brefel-Courbon [France] ; Sabrina Grolleau [France] ; Claire Thalamas [France] ; Robert Bourrel [France] ; Valérie Allaria-Lapierre [France] ; Robert Loï [France] ; Joelle Micallef-Roll [France] ; Maryse Lapeyre-Mestre [France] | Comparison of chronic analgesic drugs prevalence in Parkinson's disease, other chronic diseases and the general population |
002199 |
Isariebel Quesada-Penate [France, Cuba] ; Carine Julcour-Lebigue [France] ; Ulises-Javier Jauregui-Haza [Cuba] ; Anne-Marie Wilhelm [France] ; Henri Delmas [France] | Comparative adsorption of levodopa from aqueous solution on different activated carbons |
002217 |
C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Robert Hauser [États-Unis] ; Paul D. Feigin [Israël] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; William Langston [États-Unis] ; Eldad Melamed [Israël] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne] | A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease |
002218 |
Olivier Rascol [France] ; Ludwig Schelosky [Suisse] | 123I-Metaiodobenzylguanidine Scintigraphy in Parkinson's Disease and Related Disorders |
002219 |
Olivier Rascol [France] | "Disease-modification" trials in Parkinson disease : Target populations, endpoints and study design |
002278 |
Olivier Rascol [France] ; Werner Poewe [Autriche] ; Andrew Lees ; Marina Aristin ; Laurence Salin ; Nolwenn Juhel ; Lisa Waldhauser ; Thomas Schindler | Tesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS Study. |
002298 |
Catherine Arnaud [France] ; Melanie White-Koning ; Susan Ishoy Michelsen ; Jackie Parkes ; Kathryn Parkinson ; Ute Thyen ; Eva Beckung ; Heather O. Dickinson ; Jerome Fauconnier ; Marco Marcelli ; Vicki Mcmanus ; Allan Colver | Parent-reported quality of life of children with cerebral palsy in Europe. |
002336 |
Joffrey Zoll [France] ; Vincent Fontaine [France] ; Pierre Gourdy [France] ; Veronique Barateau [France] ; Jose Vilar [France] ; Aurelie Leroyer [France] ; Izolina Lopes-Kam [France] ; Ziad Mallat [France] ; Jean-Francois Arnal [France] ; Patrick Henry [France] ; Gerard Tobelem [France] ; Alain Tedgui [France] | Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition |
002361 |
Hubert H. Fernandez [États-Unis] ; Dag Aarsland [Norvège] ; Gilles Fénelon [France] ; Joseph H. Friedman [États-Unis] ; Laura Marsh [États-Unis] ; Alexander I. Tröster [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Scales to assess psychosis in Parkinson's disease: Critique and recommendations |
002363 |
J. C. Sharma [Royaume-Uni] ; I. N. Ross [Royaume-Uni] ; O. Rascol [France] ; D. Brooks [Royaume-Uni] | Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight |
002368 |
Jackie Parkes [Royaume-Uni] ; Melanie White-Koning [France] ; Heather O. Dickinson [Royaume-Uni] ; Ute Thyen [Allemagne] ; Catherine Arnaud [France] ; Eva Beckung [Suède] ; Jerome Fauconnier [France] ; Marco Marcelli [Italie] ; Vicki Mcmanus [Irlande (pays)] ; Susan I. Michelsen [Danemark] ; Kathryn Parkinson [Royaume-Uni] ; Allan Colver [Royaume-Uni] | Psychological problems in children with cerebral palsy: a cross‐sectional European study |
002373 |
Christopher G. Goetz [États-Unis] ; Eugene Laska [États-Unis] ; Christine Hicking [Allemagne] ; Philippe Damier [France] ; Thomas Müller [Allemagne] ; John Nutt [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne] | Placebo influences on dyskinesia in Parkinson's disease |
002374 |
Violaine Nicolas [France] ; Jean-François Mboumba [France] ; Erik Verheyen [Belgique] ; Christiane Denys [France] ; Emilie Lecompte [France] ; Ayodeji Olayemi [Nigeria] ; Alain D. Missoup [France] ; Pionus Katuala ; Marc Colyn [France] | Phylogeographic structure and regional history of Lemniscomys striatus (Rodentia: Muridae) in tropical Africa |
002381 |
Christopher G. Goetz [États-Unis] ; Barbara C. Tilley [États-Unis] ; Stephanie R. Shaftman [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Matthew B. Stern [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lang [Canada] ; Andrew Lees [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Lewitt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis] | Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results |
002390 |
N. André [Pays-Bas, Royaume-Uni, France, Inde] ; M. Blanc [France] ; S. Maurice [France] ; P. Schippers [France] ; E. Pallier [France] ; T. I. Gombosi [États-Unis] ; K. C. Hansen [États-Unis] ; D. T. Young [États-Unis] ; F. J. Crary [États-Unis] ; S. Bolton [États-Unis] ; E. C. Sittler [États-Unis] ; H. T. Smith [États-Unis] ; R. E. Johnson [États-Unis] ; R. A. Baragiola [États-Unis] ; A. J. Coates [Royaume-Uni] ; A. M. Rymer [États-Unis] ; M. K. Dougherty [Royaume-Uni] ; N. Achilleos [Royaume-Uni] ; C. S. Arridge [Royaume-Uni] ; S. M. Krimigis [États-Unis] ; D. G. Mitchell [États-Unis] ; N. Krupp [Allemagne] ; D. C. Hamilton [États-Unis] ; I. Dandouras [France] ; D. A. Gurnett [États-Unis] ; W. S. Kurth [États-Unis] ; P. Louarn [France] ; R. Srama [Allemagne] ; S. Kempf [Allemagne] ; H. J. Waite [États-Unis] ; L. W. Esposito [États-Unis] ; J. T. Clarke [États-Unis] | Identification of Saturn's magnetospheric regions and associated plasma processes: Synopsis of Cassini observations during orbit insertion |
002395 |
E. Beckung [Suède] ; M. White-Koning [France] ; M. Marcelli [Italie] ; V. Mcmanus [Irlande (pays)] ; S. Michelsen [Danemark] ; J. Parkes ; K. Parkinson [Royaume-Uni] ; U. Thyen [Allemagne] ; C. Arnaud [France] ; J. Fauconnier ; A. Colver [Royaume-Uni] | Health status of children with cerebral palsy living in Europe: a multi‐centre study |
002419 |
Laurence Nègre-Pagès [France] ; Wafa Regragui [Maroc] ; Didier Bouhassira [France] ; Héléne Grandjean [France] ; Olivier Rascol [France] | Chronic pain in Parkinson's disease: The cross‐sectional French DoPaMiP survey |
002429 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Cristina Sampaio [Portugal] ; Werner Poewe [Autriche] ; Oliver Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations |
002430 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Christina Sampaio [Portugal] ; Werner Poewe [Autriche] ; Oliver Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Anxiety rating scales in Parkinson's disease: Critique and recommendations |
002432 |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
002443 |
O. Rascol [France] | Thérapeutiques du stade précoce de la maladie de Parkinson |
002453 |
Jessica Tallet [France] | Rôle de l'inhibition dans la mémorisation de coordinations motrices complexes |
002488 |
Olivier Rascol [France] ; Werner Poewe [Autriche] ; Andrew Lees [Royaume-Uni] ; Marina Aristin [France] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Lisa Waldhauser [Allemagne] ; Thomas Schindler [Allemagne] | Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations : The ADVANS Study |
002505 |
Luca Ferraro [Italie] ; Maria Cristina Tomasini [Italie] ; Roberta Mazza [Italie] ; Kjell Fuxe [Suède] ; Jacqueline Fournier [France] ; Sergio Tanganelli [Italie] ; Tiziana Antonelli [Italie] | Neurotensin receptors as modulators of glutamatergic transmission |
002510 |
Daniel Alvarez-Fischer [France] ; Serge Guerreiro [France] ; Stephane Hunot [France] ; Francoise Saurini [France] ; Marc Marien [France] ; Pierre Sokoloff [France] ; Etienne C. Hirsch [France] ; Andreas Hartmann [France] ; Patrick P. Michel [France] | Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid |
002540 |
Laurence Negre-Pages [France] ; Wafa Regragui [Maroc] ; Didier Bouhassira [France] ; Hélène Grandjean [France] ; Olivier Rascol [France] | Chronic Pain in Parkinson's Disease : The Cross-Sectional French DoPaMiP Survey |
002627 |
Melanie White-Koning [France] ; Catherine Arnaud ; Heather O. Dickinson ; Ute Thyen ; Eva Beckung ; Jerome Fauconnier ; Vicki Mcmanus ; Susan I. Michelsen ; Jackie Parkes ; Kathryn Parkinson ; Giorgio Schirripa ; Allan Colver | Determinants of child-parent agreement in quality-of-life reports: a European study of children with cerebral palsy. |
002659 |
Betchaida D. Payot ; Sebastien Jego ; Rene C. Maury ; Mireille Polve ; Michel Gregoire [France] ; Georges Ceuleneer [France] ; Rodolfo A. Tamayo Jr ; Graciano P. Yumul Jr [Philippines] ; Herve Bellon ; Joseph Cotten | The oceanic substratum of Northern Luzon: Evidence from xenoliths within Monglo adakite (the Philippines) |
002661 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
002665 |
Yasuo Nakabayashi [Japon] ; Andrea Erxleben ; Ulla Létinois [France] ; Geneviève Pratviel [France] ; Bernard Meunier [France] ; Lars Holland ; Bernhard Lippert [Allemagne] | Spontaneous Reduction of Mixed 2,2′‐Bipyridine/Methylamine/Chloro Complexes of PtIV in Water in the Presence of Light Is Accompanied by Complex Isomerization, Loss of Methylamine, and Formation of a Strong Oxidant, Presumably HOCl |
002667 |
Joaquim Ferreira [Portugal] ; João Maia Silva [Portugal] ; Rita Freire [Portugal] ; João Pignatelli [Portugal] ; Leonor Correia Guedes [Portugal] ; Alexandra Feij [Portugal] ; Mário Miguel Rosa [Portugal] ; Miguel Coelho [Portugal] ; João Costa [Portugal] ; Ana Noronha [Portugal] ; Russell Hewett [Portugal] ; A. Marques Gomes [Portugal] ; J. L. Cirne De Castro [Portugal] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Skin cancers and precancerous lesions in Parkinson's disease patients |
002670 |
Christopher G. Goetz [États-Unis] ; Philippe Damier [France] ; Christine Hicking [Allemagne] ; Eugene Laska [États-Unis] ; Thomas Müller [Allemagne] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne] | Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double‐blind placebo‐controlled trial |
002671 |
Björn Holmberg [Suède] ; Jan-Ove Johansson [Suède] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Adriana Cardozo [Espagne] ; Nil Dizdar [Suède] ; Olivier Rascol [France] ; Tarik Slaoui [France] | Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study |
002689 |
Christopher G. Goetz [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Matthew B. Stern [États-Unis] ; Barbara C. Tilley [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lang [Canada] ; Andrew Lees [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Lewitt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis] | Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan |
002696 |
Sonia Alibert-Fouet ; Isabelle Seguy [France] ; Jean-François Bobo [France] ; Pierre Destruel [France] ; Harald Bock [France] | Liquid‐Crystalline and Electron‐Deficient Coronene Oligocarboxylic Esters and Imides By Twofold Benzogenic Diels–Alder Reactions on Perylenes |
002698 |
A. Gerdelat-Mas [France] ; M. Simonetta-Moreau [France] ; C. Thalamas [France] ; F. Ory-Magne [France] ; T. Slaoui [France] ; O. Rascol [France] ; C. Brefel-Courbon [France] | Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study |
002727 |
Anette Schrag [Royaume-Uni] ; Paolo Barone [Italie] ; Richard G. Brown [Royaume-Uni] ; Albert F. G. Leentjens [Pays-Bas] ; William M. Mcdonald [États-Unis] ; Sergio Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Depression rating scales in Parkinson's disease: Critique and recommendations |
002734 |
Jean-Claude Micheau [France] ; Jianzhang Zhao [République populaire de Chine] | Cis/trans configurations of the peptide CN bonds: isomerization and photoswitching |
002776 |
T. Slaoui [France] ; A. Mas-Gerdelat [France] ; F. Ory-Magne [France] ; O. Rascol [France] ; C. Brefel-Courbon [France] | La lévodopa modifie les seuils nociceptifs chez le patient parkinsonien |
002797 |
Patrick P. Michel [France] ; Daniel Alvarez-Fischer [France] ; Serge Guerreiro [France] ; Audrey Hild [France] ; Andreas Hartmann [France] ; Etienne C. Hirsch [France] | Role of activity-dependent mechanisms in the control of dopaminergic neuron survival |
002831 |
Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] ; Marion Simonetta-Moreau [France] ; Nelly Fabre [France] ; Jean Albert Lotterie [France] ; Patrick Chaynes [France] ; Isabelle Berry [France] ; Yves Lazorthes [France] ; Olivier Rascol [France] | Does ageing influence deep brain stimulation outcomes in Parkinson's disease? |
002941 |
Isabelle Le Ber [France] ; Eric Guedj [France] ; Audrey Gabelle [France] ; Patrice Verpillat [France] ; Magali Volteau [France] ; Catherine Thomas-Anterion [France] ; Marielle Decousus [France] ; Didier Hannequin [France] ; Pierre Véra [France] ; Lucette Lacomblez [France] ; Agnès Camuzat [France] ; Mira Didic [France] ; Michèle Puel [France] ; Jean-Albert Lotterie [France] ; Véronique Golfier [France] ; Anne-Marie Bernard [France] ; Martine Vercelletto [France] ; Christine Magne [France] ; François Sellal [France] ; Izzie Namer [France] ; Bernard-François Michel [France] ; Jacques Pasquier [France] ; François Salachas [France] ; Jean Bochet [France] ; Alexis Brice [France] ; Marie-Odile Habert [France] ; Bruno Dubois [France] | Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia |
002958 |
J. J. Ferreira [Portugal] ; K. Desboeuf [France] ; M. Galitzky [France] ; C. Thalamas [France] ; C. Brefel-Courbon [France] ; N. Fabre [France] ; J. Senard [France] ; J. Montastruc [France] ; C. Sampaio [Portugal] ; O. Rascol [France] | Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson's disease: a clinical survey in PD patients and age‐matched healthy volunteers |
002964 |
M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; O. Rascol [France] ; C. Sampaio [Portugal] | Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease |
002992 |
M. Mejdoubi [France] ; T. Zegermann [France] | Extensive brain calcification in idiopathic hypoparathyroidism |
002997 |
Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees [Royaume-Uni] | Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study |
002A02 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
002A04 |
Olivier Rascol [France] | Defining a minimal clinically relevant difference for the unified Parkinson's rating scale: An important but still unmet need |
002A31 |
Christophe Monnier [France] ; Jacques Girardeau [France] ; Laurent Le Mée [France] ; Mireille Polvé [France] | Along‐ridge petrological segmentation of the mantle in the Oman ophiolite |
002A57 |
Jean-Louis Montastruc [France] ; Agnès Sommet [France] ; Pascale Olivier [France] ; Haieh Bagheri [France] ; Mireille Gony [France] ; Maryse Lapeyre-Mestre [France] ; Christine Brefel-Courbon [France] ; Joachim Ferreira [Portugal] ; Laurent Schmitt [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] | Médicaments, maladie de Parkinson et syndromes parkinsoniens : actualités de pharmacovigilance |
002A96 |
Karine Desboeuf [France] ; Maryse Grau [France] ; Francoise Riche [France] ; Marc Fradin [France] ; Jacques Bez [France] ; Jean-Louis Montastruc [France] ; Jean-Michel Senard [France] | Prevalence and costs of parkinsonian syndromes associated with orthostatic hypotension |
002B28 |
A.-M. Shiarli [Royaume-Uni] ; R. Jennings [Royaume-Uni] ; J. Shi [Royaume-Uni, République populaire de Chine] ; K. Bailey [Royaume-Uni] ; Y. Davidson [Royaume-Uni] ; J. Tian [Royaume-Uni, République populaire de Chine] ; E. H. Bigio [États-Unis] ; B. Ghetti [États-Unis] ; J. R. Murrell [États-Unis] ; M. B. Delisle [France] ; S. Mirra [États-Unis] ; B. Crain [États-Unis] ; P. Zolo [Italie] ; K. Arima [Japon] ; E. Iseki [Japon] ; S. Murayama [Japon] ; H. Kretzschmar ; M. Neumann ; C. Lippa ; G. Halliday ; J. Mackenzie ; N. Khan ; R. Ravid ; D. Dickson ; Z. Wszolek ; T. Iwatsubo ; S. M. Pickering-Brown [Royaume-Uni] ; D. M. A. Mann [Royaume-Uni] | Comparison of extent of tau pathology in patients with frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease |
002B69 |
Olivier Rascol [France] | Rasagiline in the pharmacotherapy of Parkinson's disease--a review. |
002C04 |
Bao Ton-Hoang [France] ; Catherine Guynet [France] ; Donald R. Ronning [États-Unis] ; Brigitte Cointin-Marty [France] ; Fred Dyda [États-Unis] ; Michael Chandler [France] | Transposition of ISHp608, member of an unusual family of bacterial insertion sequences |
002C27 |
Isabelle M. Dixon ; Frédéric Lopez [France] ; Jean-Pierre Estève [France] ; Agueda M. Tejera [Espagne] ; María A. Blasco [Espagne] ; Geneviève Pratviel [France] ; Bernard Meunier [France] | Porphyrin Derivatives for Telomere Binding and Telomerase Inhibition |
002C29 |
Emmanuel Morelon ; Franc Ois Berthoux ; Catherine Brun-Strang ; Suzanne Fior [France] ; Re Gis Volle [France] | Partners' concerns, needs and expectations in ESRD: results of the CODIT Study |
002C42 |
O. Verhoeven [Belgique, France] ; A. Rivoldini [Belgique] ; P. Vacher [France] ; A. Mocquet [France] ; G. Choblet [France] ; M. Menvielle [France] ; V. Dehant [Belgique] ; T. Van Hoolst [Belgique] ; J. Sleewaegen [Belgique] ; J. Barriot [France] ; P. Lognonné [France] | Interior structure of terrestrial planets: Modeling Mars' mantle and its electromagnetic, geodetic, and seismic properties |
002C55 |
Leilanie O. Suerte [Philippines] ; Graciano P. Yumul [Philippines] ; Rodolfo A. Tamayo [Philippines] ; Carla B. Dimalanta [Philippines] ; Mei-Fu Zhou [République populaire de Chine] ; René C. Maury [France] ; Mireille Polvé [France] ; Cesar L. Balce [Philippines] | Geology, Geochemistry and U‐Pb SHRIMP Age of the Tacloban Ophiolite Complex, Leyte Island (Central Philippines): Implications for the Existence and Extent of the Proto‐Philippine Sea Plate |
002C62 |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 |
002C66 |
D. G. Mitchell [États-Unis] ; P. C. Brandt [États-Unis] ; E. C. Roelof [États-Unis] ; J. Dandouras [France] ; S. M. Krimigis [États-Unis] ; B. H. Mauk [États-Unis] ; C. P. Paranicas [États-Unis] ; N. Krupp [Allemagne] ; D. C. Hamilton [États-Unis] ; W. S. Kurth [États-Unis] ; P. Zarka [France] ; M. K. Dougherty [Royaume-Uni] ; E. J. Bunce [Royaume-Uni] ; D. E. Shemansky [États-Unis] | Energetic ion acceleration in Saturn's magnetotail: Substorms at Saturn? |
002C69 |
Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Claire Thalamas [France] ; Fabienne Ory [France] ; Isabelle Quelven [France] ; François Chollet [France] ; Jean Louis Montastruc [France] ; Olivier Rascol [France] | Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study |
002D45 |
Carl E. Clarke [Royaume-Uni] ; O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. Melamed [Israël] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; F. Stocchi [Italie] ; E. Tolosa [Espagne] | Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study) : a randomised, double-blind, parallel-group trial. Commentary |
002D65 |
Atul Pathak [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Jean-Michel Senard [France] | Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure |
002D74 |
Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Claire Thalamas [France] ; Fabienne Ory [France] ; Isabelle Quelven [France] ; Francois Chollet [France] ; Jean Louis Montastruc [France] ; Olivier Rascol [France] | Effect of levodopa on pain threshold in Parkinson's disease : A clinical and positron emission tomography study |
002D75 |
Thomas Debeir [France] ; Laure Ginestet [France] ; Chantal Francois [France] ; Stéphanie Laurens [France] ; Jean-Claude Martel [France] ; Philippe Chopin [France] ; Marc Marien [France] ; Francis Colpaert [France] ; Rita Raisman-Vozari [France] | Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus |
002D95 |
Atul Pathak [France] ; Valérie Raoul [France] ; Jean-Louis Montastruc [France] ; Jean-Michel Senard [France] | Adverse drug reactions related to drugs used in orthostatic hypotension : a prospective and systematic pharmacovigilance study in France |
002E34 |
Atul Pathak [France] ; Jean-Michel Senard | Pharmacology of orthostatic hypotension in Parkinson's disease: from pathophysiology to management. |
002E58 |
Patrice Péran [France] ; Jean-François Démonet [France] ; Cyril Pernet [France] ; Dominique Cardebat [France] | Verb and noun generation tasks in Huntington's disease |
002E89 |
A. Asrat [France, Éthiopie] ; P. Barbey [France] ; J. N. Ludden [France] ; L. Reisberg [France] ; G. Gleizes [France] ; D. Ayalew [Éthiopie] | Petrology and Isotope Geochemistry of the Pan-African Negash Pluton, Northern Ethiopia: Mafic–Felsic Magma Interactions During the Construction of Shallow-level Calc-alkaline Plutons |
002E92 |
S. Escrig [France, États-Unis] ; F. Capmas [France] ; B. Dupr [France] ; C. J. Allgre [France] | Osmium isotopic constraints on the nature of the DUPAL anomaly from Indian mid-ocean-ridge basalts |
002E95 |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Carl Counsell [Portugal] ; Nir Giladi [Israël] ; Robert G. Holloway [États-Unis] ; Charity G. Moore [États-Unis] ; Gregor K. Wenning [Autriche] ; Melvin D. Yahr [États-Unis] ; Lisa Seidl [États-Unis] | Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease |
002E99 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie] | Levodopa in the treatment of Parkinson's disease: Current controversies |
002F19 |
Olivier Rascol [France] ; Atul Pathak [France] ; Haleh Bagheri [France] ; Jean-Louis Montastruc [France] | Dopaminagonists and fibrotic valvular heart disease: Further considerations |
002F22 |
Gregor K. Wenning [Autriche] ; Franc Ois Tison [France] ; Klaus Seppi [Autriche] ; Cristina Sampaio [Portugal] ; Anja Diem [Autriche] ; Farid Yekhlef [France] ; Imad Ghorayeb [France] ; Fabienne Ory [France] ; Monique Galitzky [France] ; Tommaso Scaravilli [Royaume-Uni] ; Maria Bozi [Royaume-Uni] ; Carlo Colosimo [Italie] ; Sid Gilman [États-Unis] ; Clifford W. Shults [États-Unis] ; Niall P. Quinn [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] | Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS) |
002F23 |
O. Demeure [France] ; L. Liaubet [France] ; J. Riquet [France] ; D. Milan [France] | Determination of PRKAG1 coding sequence and mapping of PRKAG1 and PRKAG2 relatively to porcine back fat thickness QTL |
002F29 |
P. Pollak [France] ; F. Tison [France] ; O. Rascol [France] ; A. Destée [France] ; J J Péré [France] ; J M Senard [France] ; F. Durif [France] ; I. Bourdeix [France] | Clozapine in drug induced psychosis in Parkinson’s disease: a randomised, placebo controlled study with open follow up |
002F38 |
Gilles Angibaud [France] ; Claude Gaultier [France] ; Olivier Rascol [France] | Atypical parkinsonism and Annonaceae consumption in New Caledonia |
002F57 |
Nhan Nguyen [France] ; Vincent Pradel [France] ; Joëlle Micallef [France] ; Jean-Louis Montastruc [France] ; Olivier Blin [France] | Les syndromes parkinsoniens médicamenteux |
002F89 |
Pierre Payoux [France] ; Philippe Remy [France] ; Philipe Damier [France] ; Malika Miloudi [France] ; Isabelle Loubinoux [France] ; Bernard Pidoux [France] ; Véronique Gaura [France] ; Olivier Rascol [France] ; Yves Samson [France] ; Yves Agid [France] | Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease |
002F96 |
Howard T. J. Mount [Canada] ; Jean-Claude Martel [France] ; Paul Fluit [Canada] ; YINGJI WU [Canada] ; Eleanor Gallo-Hendrikx [Canada] ; Cristina Cosi [France] ; Marc R. Marien [France] | Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia-telangiectasia |
002F99 |
Marc R. Marien [France] ; Francis C. Colpaert [France] ; Alan C. Rosenquist [France, États-Unis] | Noradrenergic mechanisms in neurodegenerative diseases: a theory |
003028 |
Pierre Payoux [France] ; Kader Boulanouar [France] ; Christine Sarramon [France] ; Nelly Fabre [France] ; Sylvie Descombes [France] ; Monique Galitsky [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Umberto Sabatini [Italie] ; Claude Manelfe [France] ; Francois Chollet [France] ; Laurent Schmitt [France] ; Olivier Rascol [France] | Cortical motor activation in akinetic schizophrenic patients: A pilot functional MRI study |
003081 |
P. Cintas [France] ; M. Simonetta-Moreau ; F. Ory ; C. Brefel-Courbon ; N. Fabre ; P. Chaynes ; J. Sabatier ; J C Sol ; O. Rascol ; I. Berry ; Y. Lazorthes | Deep brain stimulation for parkinson's disease: correlation between intraoperative subthalamic nucleus neurophysiology and most effective contacts. |
003107 |
Anne-Sophie Villégier [France] ; Candice Drouin [France] ; Jean-Charles Bizot [France] ; Marc Marien [France] ; Jacques Glowinski [France] ; Francis Colpaërt [France] ; Jean-Pol Tassin [France] | Stimulation of postsynaptic α1b‐ and α2‐adrenergic receptors amplifies dopamine‐mediated locomotor activity in both rats and mice |
003109 |
S. Sacrista ; D. Kern ; O. Fourcade ; P. Izard ; P. Galinier [France] ; K. Samii ; B. Cathala | Spinal anaesthesia in a child with hypoplastic left heart syndrome |
003110 |
Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni] | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study |
003132 |
Olivier Rascol [France] ; Pierre Payoux [France] ; Fabienne Ory [France] ; Joaquim J. Ferreira [France, Portugal] ; Christine Brefel-Courbon [France] ; Jean-Louis Montastruc [France] | Limitations of current Parkinson's disease therapy |
003141 |
Vincent Regard [France] ; Claudio Faccenna [Italie] ; Joseph Martinod [Chili, France] ; Olivier Bellier [France] ; Jean-Charles Thomas [France] | From subduction to collision: Control of deep processes on the evolution of convergent plate boundary |
003144 |
Marc Ziegler [France] ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France] | Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6‐month, randomized, placebo‐controlled study |
003153 |
Patrice Péran [France] ; Olivier Rascol [France] ; Jean-François Démonet [France] ; Pierre Celsis [France] ; Jean-Luc Nespoulous [France] ; Bruno Dubois [France] ; Dominique Cardebat [France] | Deficit of verb generation in nondemented patients with Parkinson's disease |
003155 |
Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Clinical and economic analysis of spa therapy in Parkinson's disease |
003156 |
Frédéric Courbon [France] ; Christine Brefel-Courbon [France] ; Claire Thalamas [France] ; Marie Jeanne Alibelli [France] ; Isabelle Berry [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease |
003171 |
Jean-Michel Senard [France] | Troubles de la régulation tensionnelle au cours de la maladie de Parkinson idiopathique : Régulation de la pression artérielle et ses troubles chez le sujet âgé |
003211 |
J.-L. Montastruc [France] ; L. Schmitt [France] ; H. Bagheri [France] | Comportement pathologique de jeu au cours d'une maladie de Parkinson traitée par lévodopa et bromocriptine |
003220 |
Stéphane Thobois [France] ; Maria-Joao Ribeiro [France] ; Ebba Lohmann [France] ; Alexandra Dürr [France] ; Pierre Pollak [France] ; Olivier Rascol [France] ; Stéphane Guillouet [France] ; Elizabeth Chapoy [France] ; Nicolas Costes [France] ; Yves Agid [France] ; Philippe Remy [France] ; Alexis Brice [France] ; Emmanuel Broussolle [France] | Young-onset Parkinson disease with and without parkin gene mutations: A fluorodopa F 18 positron emission tomography study |
003226 |
Olivier Rascol [France] ; C. Brefel-Courbon [France] ; P. Payoux [France] ; J. Ferreira [Portugal] | The management of patients with early Parkinson's disease |
003231 |
Caroline Prunier [France] ; Pierre Payoux [France] ; Denis Guilloteau [France] ; Sylvie Chalon [France] ; Bruno Giraudeau [France] ; Cynthia Majorel [France] ; Mathieu Tafani [France] ; Erwan Bezard [France] ; Jean-Paul Esquerre [France] ; Jean-Louis Baulieu [France] | Quantification of dopamine transporter by 123I-PE2I SPECT and the noninvasive Logan graphical method in Parkinson's disease |
003260 |
G. Fenelon [France] ; S. Gimenez-Roldan [Espagne] ; J. L. Montastruc [France] ; F. Bermejo [Espagne] ; F. Durif [France] ; I. Bourdeix [France] ; J.-J. Pere [Espagne] ; L. Galiano [Suisse] ; J. Schadrack | Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study |
003261 |
S. Baker [France] ; E. Moyse [France] ; F. Jourdan [France] ; F. Colpaert [France] ; J. C. Martel [France] ; M. Marien [France] | Effects of the α2-ADRENORECEPTOR antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: Selective protection against neuronal death |
003273 |
Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Clinical and economic analysis of spa therapy in Parkinson's disease |
003303 |
Christine Brefel-Courbon [France] | [Parkinson disease and the noradrenaline system]. |
003305 |
O. Rascol [France] ; J J Ferreira ; P. Payoux ; Ch Brefel-Courbon ; J L Montastruc | [Management of levodopa-induced dyskinesia]. |
003311 |
M. Simonetta Moreau [France] ; S. Meunier ; M. Vidailhet ; S. Pol ; M. Galitzky ; O. Rascol | Transmission of group II heteronymous pathways is enhanced in rigid lower limb of de novo patients with Parkinson's disease. |
003313 |
O. Rascol [France] ; P. Payoux ; J. Ferreira ; C. Brefel-Courbon | The management of patients with early Parkinson's disease. |
003386 |
Clara Deser [États-Unis] ; Marika Holland [États-Unis] ; Gilles Reverdin [France] ; Michael Timlin [États-Unis] | Decadal variations in Labrador Sea ice cover and North Atlantic sea surface temperatures |
003392 |
Joserra Díez [Espagne] ; Arturo Elosegi [Espagne] ; Eric Chauvet [France] ; Jesús Pozo [Espagne] | Breakdown of wood in the Agüera stream |
003398 |
Agne S Coste [France] ; Marie D. Linas [France] ; Sophie Cassaing [France] ; Jose Bernad [France] ; Sandrine Chalmeton [France] ; Jean P. Se Gue La [France] ; Bernard Pipy [France] | A sub-inhibitory concentration of amphotericin B enhances candidastatic activity of interferon-γ- and interleukin-13-treated murine peritoneal macrophages |
003421 |
O. Rascol [France] ; J.-J. Ferreira [Portugal] ; P. Payoux [France] ; Ch. Brefel-Courbon [France] ; J.-L. Montastruc [France] | Prise en charge des dyskinésies par la lévodopa |
003431 |
Christine Brefel-Courbon [France] | Maladie de Parkinson et système noradrénergique |
003463 |
Olivier Rascol [France] ; Christopher Goetz [États-Unis] ; William Koller [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Autriche] | Treatment interventions for Parkinson's disease: an evidence based assessment |
003464 |
M. Simonetta Moreau [France] ; S. Meunier [France] ; M. Vidailhet [France] ; S. Pol [France] ; M. Galitzky [France] ; O. Rascol [France] | Transmission of group II heteronymous pathways is enhanced in rigid lower limb of de novo patients with Parkinson's disease |
003478 |
T. Debeir [France] ; M. Marien [France] ; P. Chopin [France] ; J.-C. Martel [France] ; F. Colpaert [France] ; R. Raisman-Vozari [France] | Protective effects of the α2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat |
003511 |
A. Angles [France] ; H. Bagheri [France] ; S. Saivin [France] ; J. L. Montastruc [France] | Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease |
003524 |
A. D. Korczyn [Israël] ; C. Thalamas [France] ; C. H. Adler [États-Unis] | Dosing with ropinirole in a clinical setting |
003543 |
Patrice Verpillat [France] ; Agnès Camuzat [France] ; Didier Hannequin [France] ; Catherine Thomas-Anterion [France] ; Michèle Puel [France] ; Serge Belliard [France] ; Bruno Dubois [France] ; Mira Didic [France] ; Bernard-Francois Michel [France] ; Lucette Lacomblez [France] ; Olivier Moreaud [France] ; Francois Sellal [France] ; Véronique Golfier [France] ; Dominique Campion [France] ; Francoise Clerget-Darpoux [France] ; Alexis Brice [France] | Association between the extended tau haplotype and frontotemporal dementia |
003549 |
E. R. Brunt [Pays-Bas] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; J.-L. Montastruc [France] ; F. Stocchi [Italie] | A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa |
003551 |
K. Ray Chaudhuri [Royaume-Uni] ; Suvankar Pal [Royaume-Uni] ; Christine Brefel-Courbon [France] | 'Sleep attacks' or 'Unintended sleep episodes' occur with dopamine agonists: Is this a class effect? |
003568 |
F. Chollet [France] ; I. Loubinoux ; J. Pariente ; C. Carel ; J F Albucher ; O. Rascol ; B. Guiraud-Chaumeil | [Pharmacologic modification of cerebral activity: value of functional neuroimaging]. |
003572 |
O. Rascol [France] ; N. Fabre ; C. Brefel-Courbon ; J L Montastruc | The pharmacologic treatment of gait ignition failure. |
003611 |
P. Léophonte [France] ; F. Neukirch [France] | Vaccination anti-pneumococcique : place et indications dans la prévention des infections communautaires des voies respiratoires inférieures |
003647 |
Marie Foussard [France] ; Stéphanie Cabantous [France] ; Jean-Denis Pédelacq [France] ; Valérie Guillet [France] ; Samuel Tranier [France] ; Lionel Mourey [France] ; Catherine Birck [France] ; Jean-Pierre Samama [France] | The molecular puzzle of two-component signaling cascades |
003664 |
Sébastien Lebonnois [France] ; Dominique Toublanc [France] ; Frederic Hourdin [France] ; Pascal Rannou [France] | Seasonal Variations of Titan's Atmospheric Composition |
003670 |
I. Séguy [France] ; R. Mamy [France] ; P. Destruel [France] ; P. Jolinat [France] ; H. Bock [France] | Photoemission study of the ITO/triphenylene/perylene/Al interfaces |
003671 |
Rodolfo A. Tamayo Jr ; Graciano P. Yumul Jr [Colombie] ; René C. Maury [France] ; Mireille Polvé [France] ; Joseph Cotten [France] ; Marcel Bohn [France] | Petrochemical Investigation of the Antique Ophiolite (Philippines): Implications on Volcanogenic Massive Sulfide and Podiform Chromitite Deposits |
003691 |
Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France] | Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease |
003704 |
Philippe De Mas [France] ; Myriam Daudin ; Marie-Claire Vincent [France] ; Georges Bourrouillou [France] ; Patrick Calvas [France] ; Roger Mieusset ; Louis Bujan | Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin |
003718 |
P. Gouet [France] ; N. Chinardet [France] ; M. Welch [France] ; V. Guillet [France] ; S. Cabantous [France] ; C. Birck [France] ; L. Mourey [France] ; J. Samama [France] | Further insights into the mechanism of function of the response regulator CheY from crystallographic studies of the CheY–CheA124–257 complex |
003739 |
Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie] | Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease |
003744 |
M. Pelat [France] ; P. Verwaerde [France] ; M. A. Tran [France] ; M. Berlan [France] ; J. M. Senard [France] ; J. L. Montastruc [France] | Changes in vascular alpha1‐ and alpha2‐adrenoceptor responsiveness by selegiline treatment |
003805 |
Jean-Louis Montastruc [France] ; Christine Brefel-Courbon [France] ; Jean-Michel Senard [France] ; Haleh Bagheri [France] ; Joaquim Ferreira [France] ; Olivier Rascol [France] ; Maryse Lapeyre-Mestre [France] | Sleep attacks and antiparkinsonian drugs : A pilot prospective pharmacoepidemiologic study |
003811 |
Jean-Michel Senard [France] ; Christine Brefel-Courbon [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Orthostatic hypotension in patients with Parkinson's disease : Pathophysiology and management |
003824 |
O. Rascol [France] ; J. G. Nutt [États-Unis] ; O. Blin [France] ; C. G. Goetz [États-Unis] ; J. M. Trugman [États-Unis] ; C. Soubrouillard [France] ; J. H. Carter [États-Unis] ; L. J. Currie [États-Unis] ; N. Fabre [France] ; C. Thalamas [France] ; W. J. Giardina [États-Unis] ; S. Wright [États-Unis] | Induction by Dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with parkinson Disease |
003828 |
O. Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease |
003839 |
S. Descombes [France] ; A. M. Bonnet [France] ; U. E. Gasser [Suisse] ; C. Thalamas [France] ; J. Dingemanse [Suisse] ; I. Arnulf [France] ; M. P. Bareille [France] ; Yves Agid [France] ; O. Rascol [France] | Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease |
003840 |
Olivier Rascol [France] ; Joaquim J. Ferreira [Portugal] ; Claire Thalamas [France] ; Monique Galitsky [France] ; Jean-Louis Montastruc [France] | Dopamine agonists: Their role in the management of Parkinson's disease |
003864 |
O. Rascol [France] ; J L Montastruc | [Role of dopaminergic agonists]. |
003869 |
O. Rascol [France] | The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease. |
003872 |
J J Ferreira [France] ; O. Rascol | Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease. |
003895 |
Jj Ferreira [France, Portugal] ; M. Galitzky [France] ; Jl Montastruc [France] ; O. Rascol [France] | Sleep attacks and Parkinson's disease treatment |
003912 |
Laura Raimondi [Italie] ; Grazia Banchelli [Italie] ; Lucia Sgromo [Italie] ; Renato Pirisino [Italie] ; Magalie Ner [France] ; Angelo Parini [France] ; Claudie Cambon [France] | Hydrogen peroxide generation by monoamine oxidases in rat white adipocytes: role on cAMP production |
003920 |
Franoise Lauga-Reyrel [France] ; Marc Deconchat [France] | Diversity within the Collembola community in fragmented coppice forests in south-western France |
003953 |
Luc Cynober [France] ; Emmanuel Alix [France] ; Franck Arnaud-Battandier [France] ; Marc Bonnefoy [France] ; Patrice Brocker [France] ; Marie-Josephe Cals [France] ; Christine Cherbut [France] ; Claire Coplo [France] ; Monique Ferry [France] ; Anne Ghisolfi-Marque [France] ; Thierry Kravtchenko [France] ; Bruno Lesourd [France] ; Catherine Mignot [France] ; Philippe Patureau Mirand [France] | Apports nutritionnels conseillés chez la personne âgée |
003999 |
Chakib El Adlouni [France, Maroc] ; Eric Pinelli [France] ; Brigitte Azémar [France] ; Driss Zaoui [Maroc] ; Philippe Beaune [France] ; Annie Pfohl-Leszkowicz [France] | Phenobarbital increases DNA adduct and metabolites formed by ochratoxin A: Role of CYP 2C9 and microsomal glutathione‐S‐transferase |
003A46 |
P. Guerre [France] ; T. Pineau [France] ; P. Costet [France] ; V. Burgat [France] ; P. Galtier [France] | Effects of AFB1 on CYP 1A1, 1A2 and 3A6 mRNA, and P450 expression in primary culture of rabbit hepatocytes |
003A60 |
C. Warren Olanow [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] | Continuous dopamine-receptor stimulation in early Parkinson's disease |
003A63 |
G. Geraud [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; J. Olesen [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; V. Pfaffenrath [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; P. Tfelt-Hansen [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; R. Zupping [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; H-C Diener [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; R. Sweet [France, Danemark, Allemagne, Estonie, Royaume-Uni] | Comparison of the Efficacy of Zolmitriptan and Sumatriptan: Issues in Migraine Trial Design |
003B07 |
C. Brefel-Courbon [France] | Quelles stratégies médicamenteuses sont à conseiller à la phase évoluée de la maladie de Parkinson |
003B28 |
O. Rascol [France] ; J.-L. Montastruc [France] | La place des agonistes dopaminergiques |
003B58 |
O. Rascol [France] | The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease |
003B68 |
Patrice Mayer [France] ; Pascale Brunel [France] ; Céline Chaplain [France] ; Christel Piedecoq [France] ; Francis Calmel [France] ; Philippe Schambel [France] ; Philippe Chopin [France] ; Thierry Wurch [France] ; Petrus J. Pauwels [France] ; Marc Marien [France] ; Jean-Louis Vidaluc [France] ; Thierry Imbert [France] | New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with α2-Adrenoceptor antagonist activity |
003B73 |
O. Rascol [France] | Medical treatment of levodopa-induced dyskinesias |
003C14 |
Jean-Louis Montastruc [France] ; Cathy Chaumerliac [France] ; Karine Desboeuf [France] ; Mimosa Manika [France] ; Haleh Bagheri [France] ; Olivier Rascol [France] ; Maryse Lapeyre-Mestre [France] | Adverse drug reactions to selegiline : A review of the French Pharmacovigilance Database |
003C16 |
O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; P. P. De Deyn [Belgique] ; C. E. Clarke [Royaume-Uni] ; A. E. Lang [Canada] | A five-year study of the incidence of dyskinesia in patients with early parkinson's disease who were treated with ropinirole or levodopa |
003C55 |
O. Rascol [France] | Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease? |
003C58 |
O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L Montastruc | Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients. |
003C60 |
M B Delisle [France] ; J R Murrell ; R. Richardson ; J A Trofatter ; O. Rascol ; X. Soulages ; M. Mohr ; P. Calvas ; B. Ghetti | A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy. |
003C78 |
P. W. Hawkes [France] | Paperwork |
003C87 |
A. Mercier [France] ; P. Debat [France] ; John M. Saul [France] | Exotic origin of the ruby deposits of the Mangari area in SE Kenya |
003C91 |
Erwan Bezard [France] ; Christine Brefel [France] ; Francois Tison [France] ; Helene Peyro-Saintpaul [France] ; Philippe Ladure [France] ; Olivier Rascol [France] ; Christian E. Gross [France] | Effect of the α2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey |
003D01 |
Philippe Guerre [France] ; Gilberte Larrieu [France] ; Viviane Burgat [France] ; Pierre Galtier [France] | Cytochrome P450 decreases are correlated to increased microsomal oxidative damage in rabbit liver and primary cultures of rabbit hepatocytes exposed to AFB1 |
003D14 |
Nacer Abbas [France] ; Christoph B. Lücking [France] ; Sylvain Ricard [France] ; Alexandra Dürr [France] ; Vincenzo Bonifati [Italie] ; Giuseppe De Michele [Italie] ; Sandrine Bouley [France] ; Jenny R. Vaughan [Royaume-Uni] ; Thomas Gasser [Allemagne] ; Roberto Marconi [Italie] ; Emmanuel Broussolle [France] ; Christine Brefel-Courbon [France] ; Biswadjiet S. Harhangi [Pays-Bas] ; Ben A. Oostra [Pays-Bas] ; Edito Fabrizio [Italie] ; Georg A. Böhme [France] ; Laurent Pradier [France] ; Nick W. Wood [Royaume-Uni] ; Alessandro Filla [Italie] ; Giuseppe Meco [Italie] ; Patrice Denefle [France] ; Yves Agid [France] ; Alexis Brice [France] | A Wide Variety of Mutations in the Parkin Gene Are Responsible for Autosomal Recessive Parkinsonism in Europe |
003D22 |
S. Planton [France] | Réchauffement global et El Niño: une revue des connaissances actuelles |
003D29 |
D. Apcher [France] ; Y. Mehaddi [France] ; D. Cailloce [France] ; N. Nathan-Denizot [France] | La mort subite du sportif est-elle si fréquente ? |
003D59 |
Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
003D72 |
Patrice Gouet [France] ; Béatrice Fabry [France] ; Valérie Guillet [France] ; Catherine Birck [France] ; Lionel Mourey [France] ; Daniel Kahn [France] ; Jean-Pierre Samama [France] | Structural transitions in the FixJ receiver domain |
003D76 |
Erik S. S Rensen [France] ; Ian Affleck [Canada] ; David Augier [France] ; Didier Poilblanc [France] | Soliton bound-states in dimerized spin chains |
003E07 |
J. M. Soulat [France] ; D. Lauque [France] ; Y. Esquirol [France] ; M. Déprés [France] ; J. Giron [France] ; R. Claudel [France] ; P. Carles [France] | High‐resolution computed tomography abnormalities in ex‐insulators annually exposed to asbestos dust |
003E14 |
F. Bartolomei [France] ; G. Farnarier [France] ; Z. Elias [France] ; G. Bronsard [France] ; S. Soulayrol [France] ; A. Bonnet [France] ; B. Chave [France] ; J. L. Gastaut [France] | Facial reflex myoclonus induced by language: A neuropsychological and neurophysiological study |
003E30 |
Catherine Birck [France] ; Lionel Mourey [France] ; Patrice Gouet [France] ; Béatrice Fabry [France] ; Jörg Schumacher [France] ; Philippe Rousseau [France] ; Daniel Kahn [France] ; Jean-Pierre Samama [France] | Conformational changes induced by phosphorylation of the FixJ receiver domain |
003E49 |
Jean-Louis Montastruc [France] ; Marc Ziegler [France] ; Olivier Rascol [France] ; Muriel Malbezin [France] | A randomized, double‐blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease |
003E73 |
O. Rascol [France] | Arguments en faveur du traitement précoce de la maladie de Parkinson par les agonistes dopaminergiques |
003E98 |
W. Koek [France] | N-methyl-D-aspartate antagonists and drug discrimination |
003F04 |
C. Thalamas [France] ; A. Taylor [Royaume-Uni] ; C. Brefel-Courbon [France] ; S. Eagle [Royaume-Uni] ; K. Fitzpatrick [Royaume-Uni] ; O. Rascol [France] | Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease |
003F05 |
O. Rascol [France] | L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease : A clinical pharmacologic approach |
003F30 |
P. P. Michel [France] ; M. Marien [France] ; M. Ruberg [France] ; F. Colpaert [France] ; Yves Agid [France] | Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes |
003F34 |
O. Rascol [France] ; O. Blin [France] ; C. Thalamas [France] ; S. Descombes [France] ; C. Soubrouillard [France] ; P. Azulay [France] ; N. Fabre [France] ; F. Viallet [France] ; K. Lafnitzegger [États-Unis] ; S. Wright [États-Unis] ; J. H. Carter [États-Unis] ; J. G. Nutt [États-Unis] | ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's Disease |
003F35 |
H. Bagheri [France] ; C. Damase-Michel [France] ; M. Lapeyre-Mestre [France] ; S. Cismondo [France] ; D. O'Connell [Irlande (pays)] ; J.-M. Senard [France] ; O. Rascol [France] ; J.-L. Montastruc [France] | A study of salivary secretion in Parkinson's disease |
003F83 |
Sylvie Bourquin [France] ; Christophe Rigollet [France] ; Philippe Bourges [France] | High-resolution sequence stratigraphy of an alluvial fan–fan delta environment: stratigraphic and geodynamic implications – An example from the Keuper Chaunoy Sandstones, Paris Basin |
004039 |
Geneviève Baziard-Mouysset [France] ; Salouma Younes [France] ; Youssef Labssita [France] ; Marc Payard [France] ; Daniel-Henri Caignard [France] ; Marie-Claire Rettori [France] ; Pierre Renard [France] ; Bruno Pfeiffer [France] ; Béatrice Guardiola-Lemaitre [France] | Synthesis and structure-activity relationships of novel 2-amino alkyl chromones and related derivatives as a site-selective ligands |
004043 |
A. J. Rascol [France] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Amos D. Korczyn [Israël] ; Warner H. Poewe [Autriche] ; Fabrizzio Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study |
004052 |
Nelly Fabre [France] ; Christine Brefel [France] ; Umberto Sabatini [Italie] ; Pierre Celsis [France] ; Jean Louis Montastruc [France] ; François Chollet [France] ; François Rascol [France] | Normal frontal perfusion in patients with frozen gait |
004083 |
Nicolas Dixon [Royaume-Uni] ; Nicolas French [Royaume-Uni] ; Nicolas Kemp [Royaume-Uni] ; Nicolas Sellers [Royaume-Uni] ; Nicolas Leclerc [France] ; Nicolas Delvaux [France] ; Nicolas Rautureau [France] | Effect of Hepatic Impairment on the Pharmacokinetics of Zolmitriptan |
004084 |
J. M. Rascol [France] ; Kasia Sieradzan [Royaume-Uni] ; Hélène Peyro-Saint-Paul [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Jean Michel Senard [France] ; Philippe Ladure [France] ; Jean Louis Montastruc [France] ; Andrew Lees [Royaume-Uni] | Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy |
004086 |
Beatriz Miguel [Espagne] ; Maixent Cousy [France] ; Jean-Paul Malrieu [France] | Coupled cluster treatments of periodic systems from strongly localized reference functions: 1‐D and 2‐D spin and electron lattices |
004094 |
Beatriz Miguel [Espagne] ; Peter Wind [France] ; Nathalie Guihéry [France] ; Jean-Paul Malrieu [France] | Approaching periodic systems by a self-consistent embedding of a finite cluster |
004109 |
O. Rascol [France] ; C. Brefel-Courbon [France] ; O. Blin [France] | Pharmacologie clinique des dyskinésies induites par la L-dopa chez les malades parkinsoniens |
004125 |
J. M. Senard [France] ; J. L. Montastruc [France] | Approche pharmacologique des dysautonomies |
004128 |
C. Brefel-Courbon [France] ; C. Thalamas [France] ; H. Peyro Saint Paul [France] ; J.-M. Senard [France] ; J.-L. Montastruc [France] ; O. Rascol [France] | α2-Adrenoceptor antagonists: A new approach to Parkinson's disease? |
004134 |
A. E. Schrag [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] ; E. Brunt [Pays-Bas] ; D. Fuell [Royaume-Uni] ; A. Korczyn [Israël] ; Werner Poewe [Autriche] ; N. P. Quinn [Royaume-Uni] ; O. Rascol [France] ; F. Stocchi [Italie] | The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease |
004137 |
A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; O. Rascol [France] ; F. Stocchi [Italie] | Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study |
004138 |
O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; A. D. Korczyn [Israël] ; Werner Poewe [Autriche] ; F. Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease : A 6-month interim report of a 5-year levodopa-controlled study |
004157 |
J. L. Montastruc [France] ; M. Pelat [France] ; P. Verwaerde [France] ; C. Brefel-Courbon [France] ; M. A. Tran [France] ; O. Blin [France] ; O. Rascol [France] ; J. M. Senard [France] | Fluoxetine in orthostatic hypotension of Parkinson's disease : A clinical and experimental pilot study |
004161 |
C. Brefel [France] ; C. Thalamas [France] ; S. Rayet [France] ; A. Lopez-Gil [Royaume-Uni] ; K. Fitzpatrick [Royaume-Uni] ; S. Bullman [Royaume-Uni] ; D. R. Citerone [Royaume-Uni] ; A. C. Taylor [Royaume-Uni] ; J. L. Montastruc [France] ; O. Rascol [France] | Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients |
004163 |
U. K. Rinne [Finlande] ; F. Bracco [Italie] ; C. Chouza [Uruguay] ; E. Dupont [Danemark] ; O. Gershanik [Argentine] ; J. F. Marti Masso [Espagne] ; J. L. Montastruc [France] ; C. D. Marsden [Royaume-Uni] | Early treatment of Parkinson's Disease with cabergoline delays the onset of motor complications: Results of a double-blind levodopa controlled trial |
004174 |
D. J. Brooks [Royaume-Uni] ; R. J. Abbott [Royaume-Uni] ; A. J. Lees [Royaume-Uni] ; E. Martignoni [Italie] ; D. V. Philcox [Afrique du Sud] ; O. Rascol [France] ; R. A. C. Roos [Pays-Bas] ; H. J. Sagar [Royaume-Uni] | A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease |
004203 |
C. Gargalidis-Moudanos [France] ; N. Pizzinat ; F. Javoy-Agid ; A. Remaury ; A. Parini | I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease. |
004211 |
Ronald Palmen [France] ; Klaas J. Hellingwerf [Pays-Bas] | Uptake and processing of DNA by Acinetobacter calcoaceticus – areview |
004229 |
R. Devaux-Basseguy [France] ; A. Bergel [France] ; M. Comtat [France] | Potential applications of NAD(P)-dependent oxidoreductases in synthesis: A survey |
004237 |
J. Tkaczuk [France] ; J. C. Bes [France] ; H. De Bouet Du Portal [France] ; M. Tafani [France] ; H. Duplan [France] ; M. Abbal [France] ; Y. Lazorthes [France] ; E. Ohayon [France] | Intrathecal allograft of chromaffin cells for intractable pain treatment: A model for understanding CNS tolerance mechanisms in humans |
004256 |
Bruno J. Vellas [France, États-Unis] ; William C. Hunt [États-Unis] ; Linda J. Romero [États-Unis] ; Kathleen M. Koehler [États-Unis] ; Richard N. Baumgartner [États-Unis] ; Philip J. Garry [États-Unis, France] | Changes in nutritional status and patterns of morbidity among free-living elderly persons: A 10-year longitudinal study |
004349 |
Nathalie Andreu [France] ; Christine Damase-Michel [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Olivier Montastruc [France] | A dose‐ranging study of selegiline in patients with Parkinson's disease: Effect on platelet monoamine oxidase activity |
004365 |
J.-L. Montastruc [France] ; O. Rascol [France] ; J.-M. Senard [France] | Pharmacologie des médicaments antiparkinsoniens : bilan et perspectives : Maladie de Parkinson |
004366 |
N. Fabre [France] ; C. Brefel-Courbon [France] ; O. Rascol [France] | Parkinson « plus » : Mouvements anormaux |
004387 |
O. Rascol [France] ; N. Fabre [France] ; U. Sabatini [Italie] | Imagerie fonctionnelle |
004391 |
O. Rascol [France] ; N. Fabre [France] ; J.-L. Montastruc [France] | Fluctuations de la réponse à la L-dopa dans la maladie de Parkinson : Maladie de Parkinson - 2e partie |
004403 |
C. Soubrouillard [France] ; C. Lombardo [France] ; O. Rascol [France] ; B. Bruguerolle [France] ; O. Blin [France] | Agonistes dopaminergiques centraux D1 et traitement de la maladie de Parkinson |
004408 |
Yves Agid [France] ; A. Destee ; F. Durif ; J.-L. Montastruc ; P. Pollak | Tolcapone, bromocriptine, and Parkinson's disease |
004411 |
O. Rascol [France] ; U. Sabatini [Italie] ; N. Fabre [France] ; C. Brefel [France] ; I. Loubinoux [France] ; P. Celsis [France] ; J. M. Senard [France] ; J. L. Montastruc [France] ; F. Chollet [France] | The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients |
004420 |
J. M. Senard [France] ; S. Rai [France] ; M. Lapeyre-Mestre [France] ; C. Brefel [France] ; O. Rascol [France] ; A. Rascol [France] ; J. L. Montastruc [France] | Prevalence of orthostatic hypotension in Parkinson's disease |
004433 |
F. G. Kaddis [États-Unis] ; E. D. Clarkson ; M. J. Weber [France] ; D. J. Vandenbergh [États-Unis] ; D. M. Donovan [États-Unis] ; J. Mallet [France] ; P. Horellou [France] ; G. R. Uhl [États-Unis] ; C. R. Freed | Intrastriatal grafting of cos cells stably expressing human aromatic L-amino acid decarboxylase : Neurochemical effects |
004434 |
C. Gargalidis-Moudanos [France] ; N. Pizzinat ; F. Javoy-Agid ; A. Remaury ; A. Parini | I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease |
004437 |
J. L. Montastruc [France] ; O. Rascol [France] ; J. M. Senard [France] | Glutamate antagonists and Parkinson's disease : A review of clinical data |
004450 |
U. K. Rinne [Finlande] ; F. Bracco [Italie] ; C. Chouza [Uruguay] ; E. Dupont [Danemark] ; O. Gershanik [Argentine] ; J. F. Marti Masso [Espagne] ; J. L. Montastruc [France] ; C. D. Marsden [Royaume-Uni] ; A. Dubini [Italie] ; N. Orlando [Italie] ; R. Grimaldi [Italie] | Cabergoline in the treatment of early Parkinson's disease : Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa |
004484 |
J L Montastruc [France] ; J M Senard ; O. Rascol ; A. Rascol | Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences. |
004486 |
O. Rascol [France] ; A J Lees ; J M Senard ; Z. Pirtosek ; C. Brefel ; J L Montastruc ; D. Fuell | A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients. |
004511 |
A. Altibelli [France] ; C. Joachim [France] ; P. Sautet [France] | Interpretation of STM images: the MoS2 surface |
004522 |
Guy Berthon [France] | Chemical speciation studies in relation to aluminium metabolism and toxicity |
004526 |
L. C. Raynal [France] ; H. M. Krisch [France] ; A. J. Carpousis [France] | Bacterial poly(A) polymerase: An enzyme that modulates RNA stability |
004578 |
Isabelle P. Oswald [France] ; Stephanie L. James | Nitrogen Oxide in Host Defense against Parasites |
004600 |
Andre Goureau [France] ; Martine Yerle [France] ; Annette Schmitz [France] ; Juliette Riquet [France] ; Denis Milan [France] ; Philippe Pinton [France] ; Gerard Frelat [France] ; Joel Gellin [France] | Human and Porcine Correspondence of Chromosome Segments Using Bidirectional Chromosome Painting |
004661 |
O. Rascol [France] ; A. J. Lees ; J. M. Senard [France] ; Z. Pirtosek ; J. L. Montastruc [France] ; D. Fuell | Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease |
004682 |
M.-E. Llau [France] ; G. Durrieu [France] ; M.-A. Tran [France] ; J.-M. Senard [France] ; O. Rascol [France] ; J.-L. Montastruc [France] | A study of dopaminergic sensitivity in Parkinson's disease : Comparison in ''de novo'' and levodopa-treated patients |
004692 |
J L Montastruc [France] ; O. Rascol ; J M Senard ; G. Houin ; A. Rascol | Sublingual apomorphine: a new pharmacological approach in Parkinson's disease? |
004699 |
J M Sénard [France] ; P. Verwaerde ; O. Rascol ; J L Montastruc | Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsonians. |
004774 |
L. Cuzin [France] ; B. Marchou [France] ; J. A. Trille [France] ; J. Ch. Auvergnat [France] | Effets secondaires psychiatriques des fluoroquinolones |
004808 |
J. C. Lefèvre [France] ; M. A. Bertrand [France] ; G. Faucon [France] | Molecular analysis by pulsed-field gel electrophoresis of penicillin-resistant Streptococcus pneumoniae from Toulouse, France |
004809 |
Jean-Paul Malrieu [France] ; Beatriz Miguel [France] ; Alain Pelegatti [France] | Modified coupled cluster amplitudes |
004826 |
Jean-Louis Montastruc [France] ; Nelly Fabre [France] ; Olivier Blin [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; André Rascol [France] | Does fluoxetine aggravate Parkinson's disease? A pilot prospective study |
004872 |
P. Allain [France] ; A. Le Bouil [France] ; E. Cordillet [France] ; L. Le Quay [France] ; H. Bagheri [France] ; J. L. Montastruc | Sulfate and cysteine levels in the plasma of patients with Parkinson's disease |
004900 |
O. Rascol [France] ; U. Sabatini ; N. Fabre [France] ; J. M. Senard [France] ; M. Simonetta-Moreau [France] ; J. L. Montrastruc [France] ; M. Clanet [France] ; A. Rascol [France] | Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease |
004912 |
M E Llau [France] ; L. Nguyen ; J M Senard ; O. Rascol ; J L Montastruc | [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]. |
004931 |
Nathalie Castignolles [France] ; Didier Betbeder [France] ; Karim Ioualalen [France] ; Otto Merten [France] ; Claude Leclerc [France] ; Daniel Samain [France] ; Pierre Perrin [France] | Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors |
004934 |
A. Pavy-Le Traon [France] ; A. Rous De Feneyrols [France] ; A. Cornac [France] ; R. Abdeseelam [France] ; D. N'Uygen [France] ; M. Lazerges [France] ; A. Güell [France] ; A. Bes [France] | Psychomotor performance during a 28 day head-down tilt with and without lower body negative pressure |
004942 |
O. Blin [France] ; C. Desnuelle [France] ; O. Rascol [France] ; M. Borg [France] ; H. Peyro Saint Paul [France] ; J. P. Azulay [France] ; F. Billé [France] ; D. Figarella [France] ; F. Coulom [France] ; J. F. Pellissier [France] ; J. L. Montastruc [France] ; M. Chatel [France] ; G. Serratrice [France] | Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy |
004945 |
Sandra Da Re [France] ; Stéphane Bertagnoli [France] ; Joëlle Fourment [France] ; Jean-Marc Reyrat [France] ; Daniel Kahn [France] | Intramolecular signal transduction within the FixJ transcriptional activator: in vitro evidence for the inhibitory effect of the phosphorylatable regulatory domain |
004A00 |
Jacques Batut [France] ; Pierre Boistard [France] | Oxygen control in Rhizobium |
004A02 |
O. Rascol [France] ; U. Sabatini [France] ; F. Chollet [France] ; N. Fabre [France] ; J M Senard [France] ; J L Montastruc [France] ; P. Celsis [France] ; J P Marc-Vergnes [France] ; A. Rascol [France] | Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. |
004A26 |
Jl Montastruc [France] ; Me Llau [France] ; O. Rascol [France] ; Jm Senard [France] | Drug‐induced parkinsonism: a review |
004A33 |
P. Laurent [France] ; P. Clerc [États-Unis] ; M. G. Mattei [France] ; P. Forgez [France] ; X. Dumont [France] ; P. Ferrara [France] ; D. Caput [France] ; W. Rostene [France] | Chromosomal localization of mouse and human neurotensin receptor genes |
004A44 |
J L Montastruc [France] ; O. Rascol [France] ; J M Senard [France] ; A. Rascol [France] | A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up. |
004A76 |
M. Galinier [France] ; J. M. Senard [France] ; P. Valet [France] ; J. P. Doazan [France] ; G. Durrieu [France] ; M. A. Tran [France] ; J. L. Monstastruc [France] ; J. P. Bounhoure | Relationship between arterial blood pressure disturbances and alpha adrenoceptor density |
004A78 |
O. Rascol [France] ; N. Fabre [France] ; O. Blin ; J. Poulik [France] ; U. Sabatini [France] ; J.-M. Senard [France] ; M. Ane [France] ; J.-L. Montastruc [France] ; A. Rascol | Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease |
004A80 |
H. Bagheri [France] ; M. Berlan ; J. M. Senard ; O. Rascol ; J. L. Montastruc | Lacrimation in Parkinson's disease |
004A93 |
J.-F. Demonet [France] ; P. Celsis [France] ; A. Agniel [France] ; D. Cardebat [France] ; O. Rascol [France] ; J.-P. Marc-Vegnes [France] | Activation of regional cerebral blood flow by a memorization task in early Parkinson's disease patients and normal subjects |
004B05 |
M. Briley [France] | Noradrenergic mechanisms in Parkinson's disease. |
004B41 |
Jean-Michel Senard [France] ; Jean-Louis Montastruc [France] | Adrenoceptor regulation in orthostatic hypotension during autonomic failure |
004B62 |
Philippe Martin [France] | Vegetation responses and feedbacks to climate: a review of models and processes |
004B72 |
J. Fournier [France] ; R. Steinberg [France] ; T. Gauthier [France] ; P. E. Keane [France] ; U. Guzzi [Italie] ; F. X. Coudé [France] ; I. Bougault [France] ; J. P. Maffrand [France] ; P. Soubrié [France] ; G. Le Fur [France] | Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates |
004B74 |
Jean-Marc Grognet [France] ; Thierry Ardouin [France] ; Michel Istin [France] ; Alain Vandais [France] ; Jean-Pierre Noel [France] ; Ghassoub Rima [France] ; Jacques Satge [France] ; Christian Pradel [France] ; Henri Sentenac-Roumanou [France] ; Claude Lion [France] | Production and characterization of antibodies directed against organophosphorus nerve agent VX |
004C23 |
M. Lescure-Ducay [France] ; J. M. Queyrau ; A. Bahna ; A. Dechandol ; C. Goutner ; M. Charrancon ; H. Berthoumieu ; J. P. Donzeau | Evaluation des propriétés électrophysiologiques des syndromes de Wolff-Parkinson-White asymptomatiques. Comparaison avec les syndromes de Wolff-Parkinson-White symptomatiques |
004C26 |
J. M. Senard [France] ; O. Rascol [France] ; B. Chamontin [France] ; A. Rascol [France] ; J.-L. Montastruc [France] | Enregistrement ambulatoire de la pression artérielle dans l'hypotension orthostatique de la maladie de Parkinson |
004C35 |
O. J. Rascol [France] ; M. Clanet [France] ; J. M. Senard [France] ; J. L. Montastruc [France] ; A. Rascol [France] | Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophy |
004C51 |
J. M. Senard [France] ; O. Rascol [France] ; A. Rascol ; J. L. Montastruc [France] | Lack of yohimbine effect on ambulatory blood pressure recording : a double-blind cross-over trial in Parkinsonians with orthostatic hypotension |
004C52 |
O. J. Rascol [France] ; U. Sabatini [France] ; F. Chollet [France] ; J. L. Montastruc [France] ; J. P. Marc-Vergnes [France] ; A. Rascol [France] | Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease : improvement by the dopamine agonist apomorphine |
004C61 |
J. M. Senard [France] ; O. Rascol [France] ; G. Durrieu [France] ; M. A. Tran [France] ; M. Berlan [France] ; A. Rascol ; J. L. Montastruc | Effects of Yohimbine on plasma catecholamine levels in orthostatic hypotension related to Pakinson disease or multiple system atrophy |
004C65 |
J. L. Montastruc [France] ; O. Rascol ; J. M. Senard | Current status of dopamine agonists in Parkinson's disease management |
004C70 |
N. Fabre [France] ; J. L. Montastruc ; O. Rascol | Alopecia : an adverse effect of bromocriptine |
004D00 |
Djamila Dermoun [France] ; Daniel Chaumont [France] ; Jean-Marc Thebault [France] ; Alain Dauta [France] | Modelling of growth of Porphyridium cruentum in connection with two interdependent factors: Light and temperature |
004D26 |
J. L. Montastruc [France] ; J. M. Senard [France] | Mécanismes physiologiques d'adaptation à l'orthostatisme |
004D53 |
Pascale De Philip [France] ; Eric Soupène [France] ; Jacques Batut [France] ; Pierre Boistard [France] | Modular structure of the FixL protein of Rhizobium meliloti |
004D71 |
Robert Emre [Suisse] ; U. K. Rinne [Finlande] ; A. Rascol [France] ; A. Lees [Royaume-Uni] ; Yves Agid [France] ; X. Lataste [Suisse] | Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease |
004D83 |
W. James Kennedy [Royaume-Uni] ; Michel Hansotte [France] ; Michel Bilotte [France] ; Jacqueline Burnett [Royaume-Uni] | Ammonites and Nannofossils from the Campanian of Nalzen (Ariège, France) |
004D84 |
Jean-Michel Senard [France] ; Bernard Chamontin [France] ; André Rascol [France] ; Jean-Louis Montastruc [France] | Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension |
004E33 |
O. Rascol [France] ; U. Sabatini ; F. Chollet ; P. Celsis ; J.-L. Montastruc ; J.-P. Marc-Vergnes ; A. Rascol | Supplementary and primary sensory motor area activity in Parkinson's disease : regional cerebral blood flow changes during finger movements and effects of apomorphine |
004E38 |
A. Kastner [France] ; E. C. Hirsch ; O. Lejeune ; F. Javoy-Agid ; O. Rascol [France] ; Yves Agid [France] | Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content ? |
004E55 |
G. Durrieu [France] ; J M Senard ; M A Tran ; A. Rascol ; J L Montastruc | Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians. |
004F37 |
Chantal Gleizes [France] ; Claudine Eeckhoutte [France] ; Thierry Pineau [France] ; Michel Alvinerie [France] ; Pierre Galtier [France] | Inducing effect of oxfendazole on cytochrome P450IA2 in rabbit liver |
004F48 |
Mark O. Gessner [France] | Differences in processing dynamics of fresh and dried leaf litter in a stream ecosystem |
004F52 |
A. Agniel [France] ; P. Celsis [France] ; G. Viallard [France] ; J L Montastruc [France] ; O. Rascol [France] ; J F Demonet [France] ; J P Marc-Vergnes [France] ; A. Rascol [France] | Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries. |
004F89 |
J. L. Montrastuc [France] ; O. Rascol ; J. M. Senard ; V. Gualano ; H. Bagheri ; G. Houin ; A. Lees ; A. Rascol | Sublingual apomorphine in Parkinson's disease : a clinical and pharmacokinetic study |
004F90 |
U. Sabatini [France] ; O. Rascol ; P. Celsis ; G. Houin ; A. Rascol ; J. P. Marc-Vergnes ; J. L. Montastruc | Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms |
004F91 |
O. Rascol [France] ; U. Sabatini ; SIMONETTA-MOREAU ; J. L. Montastruc ; A. Rascol ; M. Clanet | Square wave jerks in Parkinsonian syndromes |
004F94 |
J. L. Montastruc [France] | Recent advances in the clinical pharmacology of Parkinson's disease |
005011 |
G. Durrieu [France] ; J M Senard ; O. Rascol ; M A Tran ; X. Lataste ; A. Rascol ; J L Montastruc | Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243). |
005012 |
G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J L Montastruc ; P. Montastruc | Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment. |
005036 |
U. Sabatini [France] ; O. Rascol [France] ; P. Celsis [France] ; J. P. Marc-Vergnes [France] ; J. L. Montastruc [France] | Effects of apomorphine on cerebral blood flow and extrapyramidal symptoms in Parkinson's disease |
005102 |
Brice Kitahama [France] ; Michel Denoyer [France] ; Brigitte Raynaud [France] ; Carla Borri-Voltattorni [Italie] ; Michel Weber [France] ; Michel Jouvet [France] | Aromatic L‐amino acid decarboxylase‐immunohistochemistry in the cat lower brainstem and midbrain |
005104 |
J. M. Senard [France] ; P. Valet [France] ; G. Durrieu [France] ; M. Berlan [France] ; M. A. Tran [France] ; J. L. Montastruc [France] ; A. Rascol [France] ; P. Montastruc [France] | Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension |
005110 |
J.-L. Montastruc [France] | Syndromes parkinsonines : étiologie, diagnostic, traitement |
005117 |
J.-L. Montastruc [France] ; O. Rascol ; J.-M. Senard | Les médicaments anti-parkinsoniens : bilan et nouvelles perpectives pharmacologiques |
005132 |
G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J.-L. Montastruc ; P. Montastruc | β-Adrenergic sensitivity in Parkinson's disease : effect of levodopa treatment |
005156 |
M. Berlan [France] ; O. Rascol ; J. Belin ; J P Moatti ; A. Rascol ; J L Montastruc | Alpha 2-adrenergic sensitivity in Parkinson's disease. |
005219 |
J L Montastruc [France] ; O. Rascol [France] ; A. Rascol [France] | A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up. |
005296 |
Jacques Richaud [France] | Spinal meningeal malformations in children (without meningoceles or meningomyeloceles) |
005367 |
M. Rostin [France] ; A. Pascaud [France] ; D. Lauque [France] ; F. Sorbette [France] ; P. Carles [France] ; J. L. Montastruc [France] | Enquête intensive de pharmacovigilance dans un service d'admission médicale |
005369 |
M. Delay [France] ; J. Ferrières [France] ; B. Mordant [France] ; D. Carrie [France] ; J. Calazel [France] ; P. Bernadet [France] | Apport de la stimulation œsophagienne au repos et à l'effort dans l'évaluation du syndrome de Wolff-Parkinson-White |
005380 |
M. B. Delisle [France] ; P. Gorce [France] ; E. Hirsch [France] ; J. J. Hauw [France] ; A. Rascol [France] ; H. Bouissou [France] | Motor neuron disease, parkinsonism and dementia |
005382 |
J. L. Montastruc [France] ; J. L. Celsis [France] ; A. Agniel [France] ; J. F. Demonet [France] ; B. Doyon [France] ; M. Puel [France] ; J. P. Marc-Vergnes [France] ; A. Rascol [France] | Levodopa‐induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease |
005445 |
J. Alary [France] ; J. Vandaele [France] ; C. Escrieut [France] ; R. Haran [France] | Determination of trace amounts of nickel by atomic-absorption spectrometry after carbonyl generation |
005449 |
María-Luisa Martínez Chac N [Espagne] ; Jean-Jacques Delvolvé [France] | Une faune de Rhynchonellidés du Carbonifère antévarisque des Pyrénées Centrales Françaises |
005514 |
J. Rösch [France] | The basic equations for scanning heliometer measurement of solar diameters |
005523 |
Alain Villeneuve ; Michel Berlan [France] ; Max Lafontan ; Claudine Caranobe [France] ; Bernard Boneu [France] ; André Rascol [France] ; Jean-Louis Montastruc [France] | Platelet alpha2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment |
005533 |
Merle Ruberg [France] ; France Javoy-Agid [France] ; Etienne Hirsch [France] ; Bernard Scatton [France] ; Rémy Lheureux [France] ; Jean-Jacques Hauw [France] ; Charles Duyckaerts [France] ; Françloise Gray [France] ; Ariel Morel-Maroger [France] ; André Rascol [France] ; Michel Serdaru [France] ; Michel Agid [France] | Dopaminergic and cholinergic lesions in progressive supranuclear palsy |
005588 |
J. C. Noëns [France] ; J. Pageault [France] ; G. Ratier [Pays-Bas] | Measuring electron density in coronal active regions |
005660 |
Honoré Mazarguil [France] ; Raymond Haran [France] ; Jean-Pierre Laussac [France] | The binding of aluminium to [Leu5]-enkephalin an investigation using 1H, 13C and 27Al NMR spectroscopy |
005668 |
P. W Hawkes [France] | Electron image processing: 1978–1980 |
005710 |
J. C. Noens [France] ; J. L. Leroy [France] | Measuring electron density in coronal active regions |
005730 |
Denise Mongin [France] ; Bernard Peybernes [France] | L'albien du chainon de fontfroide (zone prepyreneenne, sud de la France): Observations paleoecologiques sur le gisement de fontcouverte par l'etude des mollusques |
005731 |
S. Juskiewenski [France] ; Ph. Vaysse [France] ; J. Guitard [France] ; J. Moscovici [France] ; G. Fourtanier [France] | Innervation de la vessie et de l'urèthre |
005732 |
A. Bes [France] ; A. Guell [France] ; L. Braak [France] ; M. Farah [France] ; M. Barrère [France] | Influence de l'age sur quelques paramètres du signal doppler au niveau du système carotidien |
005817 |
M. T. Mitjavila [France] ; S. Mitjavila [France] ; N. Gas [France] ; R. Derache [France] | Influence of various surface-active agents on the activity of several enzymes in the brush border of enterocytes |
005855 |
Jean-Louis Leroy [France] | Emissions ‘froides’ dans la couronne solaire |
005904 |
J M Senard [France] ; J L Montastruc | [Pharmacologic approach to autonomic failure]. |
005920 |
Jean-Louis Montastruc [France] ; Agnès Sommet ; Pascale Olivier ; Haleh Bagheri ; Mireille Gony ; Maryse Lapeyre-Mestre ; Christine Brefel-Courbon ; Joachim Ferreira ; Laurent Schmitt ; Jean-Michel Senard ; Olivier Rascol | [Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]. |
005926 |
O. Rascol [France] ; C. Brefel-Courbon ; O. Blin | [Clinical pharmacology of dyskinesias induced by L-dopa in Parkinsonian patients]. |
005945 |
J L Montastruc [France] ; C. Brefel-Courbon ; J M Senard ; H. Bagheri ; J. Ferreira ; O. Rascol ; M. Lapeyre-Mestre | Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. |
005951 |
J L Montastruc [France] | Recent advances in the clinical pharmacology of Parkinson's disease. |
005952 |
O. Rascol [France] ; D J Brooks ; E. Melamed ; W. Oertel ; Werner Poewe ; F. Stocchi ; E. Tolosa | Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. |
005956 |
Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Nelly Fabre ; Fabienne Ory ; Umberto Spampinato ; Christine Brefel-Courbon ; Jean-Louis Montastruc ; Olivier Rascol | Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease. |
005959 |
Claire Thalamas [France] ; Iris Rajman ; Jaime Kulisevsky ; Alberto Lled ; Alison E. Mackie ; Olivier Blin ; Todd A. Gillespie ; Mary Seger ; Olivier Rascol | Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease. |